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ABBREVIATIONS AND NOMENCLATURE
Chemical compounds: Intermediates of the catalytic cycle
ADP - adenosine 5’-diphosphate O - fully-oxidized, ground state
ATP - adenosine 5’-triphosphate E or EH - one-electron reduced state
DM - n-dodecyl-b-D-maltoside R - fully-reduced state
FADH2 - flavin adenine dinucleotide (reduced) A - ferrous-oxy intermediate
Fe-S - iron-sulfur cluster P - peroxy intermediate
FMN - flavin mononucleotide F - ferryl-oxo intermediate
NAD+/
 NADH
- nicotinamide adenine dinucleotide
(oxidized/reduced form)
OH
(H or O~)
- fully-oxidized, high-energy
state
Q/QH2 - ubiquinone/ubiquinol
RubiPy - tris (2,2’-bipyridyl) ruthenium (II)
Other abbreviations:
CcO - cytochrome c oxidase
COFR - fully-reduced oxidase ligated by carbon monoxide
COMV - “mixed-valence” (two-electron reduced) oxidase ligated by carbon
monoxide
d - relative dielectric depth of the binuclear center within the membrane
Em - midpoint redox potential relative to the Standard Hydrogen Electrode
EPR - electron paramagnetic resonance
Ferryl form - state of heme-iron with +4 charge (extra oxidized)
Ferric form - state of heme-iron with +3 charge (oxidized)
Ferrous form - state of heme-iron with +2 charge (reduced)
N-side - electrically negative side of the membrane (matrix in mitochondria or
cytoplasm in bacteria)
P-side - electrically positive side of the membrane (intermembrane space in
mitochondria or periplasmic space in bacteria)
Kd - dissociation constant
Km - Michaelis-Menten constant
ROS - reactive oxygen species
DmH+ - electrochemical proton gradient
DY - electric membrane potential
t - time constant, 1/k
Amino acids:
A Ala Alanine I Ile Isoleucine R Arg Arginine
C Cys Cysteine K Lys Lysine S Ser Serine
D Asp Aspartic acid L Leu Leucine T Thr Threonine
E Glu Glutamic acid M Met Methionine V Val Valine
F Phe Phenylalanine N Asn Asparagine W Trp Tryptophan
G Gly Glycine P Pro Proline Y Tyr Tyrosine
H His Histidine Q Gln Glutamine
The numbering of amino acid residues mainly refers to the Paracoccus denitrificans enzyme; at
the same time the corresponding residue numbers for the bovine (Bos taurus) cytochrome c
oxidase are given in parentheses.
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1. INTRODUCTION
1.1 Energy Cycle in Living Organisms
All living organisms require energy for growth and reproduction, and the most important task of
all organisms is to find a way to absorb the energy in an available form and then transform it into
a usable form. The major source of energy in the biosphere is sunlight. About three billion years
ago some bacteria learned to utilize the energy of photons from the Sun and convert it into the
energy of chemical bonds in a process called photosynthesis. In this complex process the energy
of a light quantum drives the electron flux from water to carbon dioxide forming carbohydrates –
mainly glucose (Equation 1), sucrose, and starch – which eventually form the basis for the
building of biomass and growth. As a side product of the photosynthetic reaction, molecular
oxygen is released into the atmosphere.
(1)
After some time in the past, the amount of dioxygen in the atmosphere was greatly increased and
about 2-2.5 billion years ago a new line of organisms appeared. This new form of life was able to
obtain the energy it needed by transferring electrons from foodstuffs, created in photosynthesis,
to oxygen thereby releasing a great deal of energy (Equation 2). This latter process is called
respiration.
(2)
Taken  together  these  two processes  form a  closed  carbon cycle,  responsible  for  the  circulation
and transformation of energy among living organisms on Earth.
1.2 Cellular Respiration
The main foodstuffs used by cells in the cellular respiration are carbohydrates, fatty acids, and
proteins. As an example, the catabolic reaction of carbohydrates in higher organisms consists of
three main stages. The first stage is glycolysis and it takes place in the cytoplasm of the cell. In
this process glucose and other sugars are transformed into three-carbon molecules of pyruvate
with the generation of ATP and NADH. However, the amount of ATP and NADH formed at this
stage is rather small, especially when compared to subsequent steps of pyruvate disintegration.
The next two steps of energy transformation occur in mitochondria. The mitochondrion consists
of two closed membrane layers, identified as the outer and inner membranes, which divide the
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mitochondrion into two isolated compartments: the internal matrix and intermembrane space.
The outer membrane, which encloses the entire organelle, has a large number of pores formed by
the protein porin. Porin contains a relatively large internal channel that makes the outer
membrane permeable to all kinds of molecules up to 1 500 Daltons. In contrast, the inner
membrane is impermeable to any water-soluble molecules and ions, and transport of molecules
through this membrane is carried out selectively through specific transporters. The physiological
functions of the inner membrane are to house the enzymatic complexes of the respiratory chain
(also known as the electron transport chain) and to maintain an electrochemical transmembrane
proton gradient, which is subsequently used for ATP synthesis (Mitchell, 1961). Depending on
environmental conditions the inner mitochondrial membrane can be extremely enlarged into the
matrix space, increasing its capacity to contain the proteins of the respiratory chain. Unlike
eukaryotes, prokaryotes lack mitochondria and in these organisms the enzymes of the respiratory
chain are situated in the cytoplasmic membrane.
At the second stage of the catabolic reaction the molecules of pyruvate are transferred into the
matrix compartment of the mitochondria. In the matrix space pyruvate is converted to acetyl-
CoA - the substrate for the citric acid cycle (Krebs cycle), where it is finally oxidized to carbon
dioxide.  In  this  sequential  process  the  oxidation  of  one  molecule  of  acetyl-CoA  produces  one
molecule of ATP, one molecule of QH2 and three molecules of NADH. The latter two substances
are  used  as  electron  donors  in  the  last  stage  of  cellular  respiration  by  the  enzymes  of  the
respiratory chain.
The respiratory chain (Fig. 1) consists of four membrane-bound protein complexes containing
redox-active cofactors (see review by Saraste, 1999). The first enzyme in this chain is complex I
(NADH:ubiquinone oxidoreductase or NADH dehydrogenase). Complex I is the largest enzyme
of the respiratory chain composed of up to 45 different subunits (Carroll et al., 2002) with
noncovalently bound flavin mononucleotide (FMN) and at least eight iron-sulfur clusters (Fe-S)
as prosthetic groups (Hinchliffe and Sazanov, 2005). Complex I receives electrons from NADH
and use them to reduce the quinone pool in the membrane. This reaction is coupled to proton
translocation across the membrane in the stoichiometry of two protons per electron (Wikström,
1984; Bogachev et al., 1996; reviews by Yano, 2002; Hirst, 2005). It should be noted however
that in some organisms e.g. the yeast Saccharomyces cerevisiae (baker’s yeast), the
mitochondrial respiratory chain does not contain complex I as such, but several alternative
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NADH dehydrogenases. These alternative dehydrogenases can oxidize matrix and cytoplasmic
NADH but do not contribute to production of a membrane potential (Joseph-Horne et al., 2001).
The reduced quinone pool is also maintained by complex II (succinate:ubiquinone
oxidoreductase or succinate dehydrogenase), which is a component of the citric acid cycle.
Complex II contains a covalently bound FAD (flavin-adenine dinucleotide) and several Fe-S
clusters as redox cofactors and couples the oxidation of succinate to the reduction of ubiquinone
(review by Horsefield et al., 2004). In addition, the membrane domain of complex II contains
heme b, which does not participate in electron transfer itself, but most likely serves as a regulator
of the redox potentials of the cofactors and facilitates electron transfer to ubiquinone. Complex II
is not involved in proton translocation across the membrane and serves only as an electron entry
point to the energy transducing part of the respiratory chain.
Complex III (ubiquinol:cytochrome c oxidoreductase or bc1 complex)  has  11  subunits  with
several redox centers: two protohemes (cytochromes b), a membrane-anchored cytochrome c1
and a Rieske-type center (Fe2S2). Complex III transfers electrons from ubiquinol to cytochrome c
and translocates one charge across the membrane dielectric for each electron delivered to
cytochrome c, by a mechanism known as the protonmotive Q-cycle (Mitchell, 1976; Crofts,
2004 for reviews).
Finally, the terminal oxidase - complex IV (cytochrome c oxidase, CcO) - uses the electrons
from cytochrome c to reduce dioxygen to water, and links this process to proton pumping across
the  membrane.  Mammalian  CcO  consists  of  13  subunits  and  has  4  redox-active  centers:  a
bimetallic copper site (CuA), two hemes (a and a31), and another copper ion (CuB). Heme a3 and
CuB together form a catalytic site where all the chemistry of oxygen reduction to water occurs.
In the respiration process electrons from NADH are sequentially transferred through the
enzymes of the respiratory chain to the terminal electron acceptor – dioxygen. The energy
released in this reaction drives proton translocation across the membrane and creates an
electrochemical transmembrane proton gradient (DmH+ ).The full drop of redox potential from
NADH to dioxygen is about 1.15 V; however since the inner membrane cannot sustain over
~200 mV, the release of energy in a single step would be extremely inefficient. Thus, the
1 Because oxygen-binding heme has specific chemical and spectroscopic properties subscript ‘3’ after the heme
letter is used to distinguish it.
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Figure 1. Schematic representation of the mitochondrial inner membrane, including the enzymes
of the respiratory chain and ATP synthase. Based on the crystallographic structures 2FUG,
1YQ3, 1BGY, 2B4Z, 1QLE, 1BMF, 1YCE)
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respiratory chain releases the energy sequentially, step by step and can be described as a
molecular transformer that accepts the voltage provided by the redox reaction (1.15 V) and lower
it to a voltage that the membrane can sustain (~200 mV), while conserving energy by making a
corresponding increase in the current. Since the overall drop of energy from NADH to dioxygen
is in about 5 times higher than the potential on the membrane, the sequential organization of the
respiratory chain allows the utilization of the energy into the translocation of 5 charges (protons)
across the membrane. The DmH+ created in this way is mostly used by the ATP synthase
(complex V) for formation of ATP (Mitchell, 1961; Stock et al., 2000).
 The sequential oxidation of glucose to carbon dioxide is extremely efficient and provides
sufficient energy for formation of up to 31 molecules of cytoplasmic ATP per molecule of
glucose (Fig. 2). One of the main tasks in cellular bioenergetics is to understand individual
functional mechanisms of the enzymes in the respiratory chain. The present study is focused on
the terminal oxidases of the respiratory chain, which are responsible for final utilization of
electrons supplied from NADH.
Figure 2. The approximate overall efficiency of oxidation of one molecule of glucose to carbon
dioxide in the eukaryotic cell (assuming that: oxidation of 1 NADHmatrix is coupled to transfer of
10 H+ across the membrane; H+/ATPcytoplasm ratio  at  the  ATP  synthase  is  3  (ATP  synthase
efficiency) + 1 (ATP/ADP exchanger); and delivery of NADHcytoplasm into the matrix space
occurs via glutamate-aspartate shuttle and consumes 1 H+).
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2. STRUCTURE AND FUNCTION OF TERMINAL OXIDASES
2.1 Function
Cytochrome c oxidase (CcO) catalyzes the final step of respiration - reduction of molecular
oxygen. Reduction of one dioxygen to water requires four electrons that are supplied one-by-one
from the water-soluble cytochrome c on the P-side, and four protons, taken up from the N-side of
the membrane:
There are several main aspects in the functioning of CcO. First, even though the reduction of
oxygen to water is an exergonic process, coupled to release of large amounts of energy, this
reaction does not proceed spontaneously under normal conditions. The reason is the high
activation barrier. Hence, the first main role of CcO is to form favorable conditions for catalysis
and to facilitate the process of oxygen reduction to water.
Secondly, the energy released in the reaction of oxygen reduction is conserved in the form of a
transmembrane electrochemical gradient of protons across the membrane (DmH+). Formation of
DmH+ by CcO is based on two principles: vectorial chemistry and proton pumping. Since the
protons and electrons for oxygen reduction to water are taken from the different sides of the
membrane, the reaction results in net transfer of four charges across the membrane. At the same
time, the enzyme is able not only to catalyze the oxygen reduction but also to utilize the released
energy for proton pumping. In 1977 Wikström showed that reduction of molecular oxygen to
water by CcO is linked to pumping of four protons across the membrane dielectric (Wikström,
1977). Hence, the overall reaction carried out by cytochrome c oxidase can be described by the
following equation:
Thirdly, all processes involving oxygen redox chemistry are potentially extremely dangerous for
a cell due to possible formation of highly toxic reactive oxygen species (hydroxyl radical,
hydrogen peroxide, and superoxide - ROS). These oxygen compounds can induce chain reactions
of oxidative damage to fatty acids and other lipids, DNA molecules, proteins, etc. Therefore, the
mechanism of oxygen catalysis in CcO organized such that it excludes the formation of ROS and
assures complete reduction of oxygen to water (Babcock and Wikström, 1992).
TERMINAL OXIDASES
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2.2 Terminal Oxidases
In contrast to eukaryotes, where only one type of terminal oxidases (aa3-type cytochrome c
oxidase) is present, the respiratory chains in bacteria can vary extensively (Anraku and Gennis,
1987; Garcia-Horsman et al., 1994) and have multiple types of terminal oxidases (Fig. 3). The
main function of such branching is to provide bacteria with better elasticity in a variety of
environmental growth conditions. In brief, in bacteria the composition of the respiratory
pathways has been evolved for optimal growth based on the following factors:
· Maintaining the highest possible coupling efficiency (H+/e- ratio) under many different
environmental conditions for maximal yield of ATP. For example, if the oxygen tension
in the growth medium is high, then the terminal oxidases in Escherichia coli will be
mostly represented by the highly efficient cytochrome bo3,  which  uses  the  energy  of
oxygen reduction to water to pump protons. In contrast, under low-oxygen conditions, the
most pronounced will be the expression of cytochrome bd (Rice and Hempfling, 1978;
Poole, 1983). This oxidase has higher affinity to oxygen (Paper I) but does not pump
protons (Miller and Gennis, 1985; Puustinen et al., 1991). Hence, the overall amount of
energy formed in low-oxygen conditions will be decreased, but the respiratory chain will
still be able to work, providing the bacteria with energy.
· Rapid removal of excess reducing equivalents such as NADH/NADPH. Even though the
main function of the respiratory chain is to generate DmH+,  it  also  regulates  the
NAD+/NADH ratio by eliminating excess reducing equivalents. This function is very
important for organisms that have access to some alternative sources of energy such as
photosynthesis. For instance, under high-light conditions in cyanobacteria reducing
equivalents are formed extremely rapidly, and even CcO and the b6f complex working
together can not prevent over-reduction of the quinone pool in the membrane. In such a
situation cytochrome bd starts to play an important role due to its lower coupling
efficiency (Berry et al., 2002).
· Regulation of intracellular oxygen concentration. Under some specific conditions it may
be very important for bacteria to decrease the intracellular amounts of oxygen to protect
oxygen-sensitive enzymes from inhibition. For example, nitrogenases from the strict
aerobe Azotobacter vinelandii (Kelly et al., 1990) or from some enteric bacteria (Hill et
al., 1990) can be easily inhibited by high concentrations of dioxygen. Thus, on one hand
the oxygen concentration in these organisms must be kept low enough to allow nitrogen
fixation and on the other hand it must be high enough for adequate synthesis of ATP. It
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has been shown that in these bacteria cytochrome bd is a key element in the respiratory
chain, involved in the oxygen regulating process (Hill et al., 1990; Kelly et al., 1990).
Figure 3. Schematic drawing of respiratory chain branching in several aerobic organisms.
Depending on the construction of the catalytic site, terminal oxidases can be divided into two
families: the heme-copper superfamily and the cytochrome bd-type family. Most terminal
oxidases belong to the heme-copper superfamily (Garcia-Horsman et al., 1994); they are
characterized by a unique binuclear catalytic site, where all the chemistry of oxygen reduction to
water occurs. The binuclear site is located in subunit I and consists of a high-spin heme and a
copper atom, called CuB. Both high-spin heme and CuB are retained in the protein by ligation to
one and three histidine residues, respectively. In addition to the binuclear site, subunit I also
harbors  a  low-spin  heme,  which  is  ligated  by  two  histidine  residues,  and  serves  as  a  donor  of
electrons to the binuclear center. Together, the binuclear center and the electron-donating heme
form the core of the protein, which is common to all members of the heme-copper oxidase
superfamily. In bacteria, several different types of hemes (B, O or A) can be found as redox
cofactors (Calhoun et al., 1994) (Fig. 4). In addition to the core functional group, some oxidases
of  this  class  have  extra  prosthetic  groups:  for  example,  a  bimetallic  copper  site  CuA (in
cytochrome aa32), a single c-type heme (in caa3), or even several c-type hemes (cbb3).
2 The designation cytochrome aa3/bo3/caa3/cbb3 refers to the entire protein complex. The letter with subscript 3
defines the oxygen-binding heme; the letter next to it defines the type of the electron-donating low-spin heme. When
additional heme(s) is present in the oxidase its type is designated by the first italic letter.
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Figure 4. Structures of heme B, heme O, heme A, heme D (in this heme one double bond in a
pyrrole ring has been reduced, so it is actually a chlorin, rather than a real heme), and heme C
(structure of heme C is similar to heme B except that heme C is covalently bound to polypeptide
via thioether bridges).
Heme-copper oxidases can be divided into two main subgroups based on the source of electrons,
which they are able to utilize. The members of this first subgroup - cytochrome c oxidases  -
receive electrons from the water-soluble cytochrome c and are found in both eukaryotic and
bacterial organisms. The most extensively studied examples of these oxidases are mitochondrial
CcO from bovine heart; bacterial aa3-type oxidases from Paracoccus denitrificans and
Rhodobacter sphaeroides; cytochromes ba3 and caa3 from Thermus thermophilus; and
cytochrome cbb3 from various species. The second subgroup is represented by quinol-oxidases,
which are found only in bacteria. Quinol oxidases accept electrons directly from quinols in the
TERMINAL OXIDASES
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cytoplasmic membrane. The best known member of this class is cytochrome bo3 from
Escherichia coli.
The  second  family  of  terminal  respiratory  oxidases  is bd-type quinol oxidases. Compared to
heme-copper oxidases, cytochrome bd has a completely different structure at the catalytic site. It
lacks a copper atom and is most likely formed by two high-spin hemes: heme d (Fig,  4)  and
heme b595. In addition to these hemes, cytochrome bd contains a low-spin heme b558, which is
directly involved in accepting electrons from quinols (Green et al., 1986). Although this oxidase
does not pump protons across the membrane (Miller and Gennis, 1985; Puustinen et al., 1991), it
can still create DmH+ by virtue of vectorial chemistry. This results in reduced coupling efficiency
which in fact turns out to have an adaptive importance for bacteria.
2.3 Structure of Cytochrome c Oxidase
A clear understanding of the mechanism of protein function is almost impossible without a
knowledge of its 3D structure. The last decade was extremely successful in resolving the
structures of membrane bound proteins by X-ray crystallography. Even though the information
about basic composition and functioning of terminal oxidases was already known before the
crystal structures were established, the great advantage was obtained when the first
crystallographic structures of CcO were resolved (Iwata et al. 1995; Tsukihara et al., 1995).
At present, mitochondrial and bacterial, reduced and oxidized, ligand-bound and unliganded,
wild-type and mutant, cytochrome c and quinol terminal oxidases’ structures from five
organisms have been resolved with resolution up to 1.8 Å (Table 1). However, these structures
have not, by themselves, provided an explanation of the catalytic mechanism of the enzyme. For
example, the structures of the oxidized and reduced states of CcO reveal no large differences in
the spatial organization of the protein, and the molecular mechanism of CcO is still enigmatic.
Solving the structures of all intermediates in the catalytic cycle of CcO could help to answer this
question. In some cases such approach has provided invaluable information about the mechanism
of protein functioning. For instance, the structure of the light-driven proton pump
bacteriorhodopsin was solved in all main states of the photocycle, which made it possible to
create a picture of the function of this protein (Lanyi, 2004). Unfortunately, the intermediates of
the catalytic cycle of CcO are quite unstable, which makes this approach extremely difficult.
STRUCTURE
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Mammalian CcO has a molecular weight of about 200 kDa and contains 13 different polypeptide
subunits (Table 2). The three largest form the core of the enzyme and are encoded by the
mitochondrial genome, whereas the remaining 10 subunits originate from nuclear DNA (Capaldi,
1990). Bacterial CcO (Table 2) are simpler in structure and have only from three to four subunits
(Fig.  5A),  but  the  sequence  homology  of  subunits  I,  II,  and  III  to  the  corresponding  ones  of
mitochondrial CcO is extremely high (Raitio et al., 1987; Steinrucke et al., 1987). The sequence
identity between CcO from R. sphaeroides and from bovine heart is 52% for subunit I
(Shapleigh and Gennis, 1992), 39% for subunit II (Cao et al., 1991), and 50% for subunit III
(Cao et al., 1992). Thus, the bacterial terminal oxidases can be excellent models of more
complex eukaryotic oxidases for functional studies, mainly because there are easier and faster
ways to manipulate them using molecular genetic methods (Hosler et al., 1993).
3 Three-dimensional structures of terminal oxidases and other biological macromolecules can be downloaded from
RCSB Protein Data Bank (http://www.rcsb.org/pdb ).
Table 1. The list of resolved crystallographic structures of terminal oxidases.
Type Source Resolution PDB number3 Reference
aa3 bovine 2.80 Å - Tsukihara et al., 1995
aa3 bovine 2.80 Å 1OCC Tsukihara et al., 1996
aa3 bovine 2.30 Å 2OCC Yoshikawa et al., 1998
aa3-reduced bovine 2.35 Å 1OCR Yoshikawa et al., 1998
aa3-CO bound bovine 2.80 Å 1OCO Yoshikawa et al., 1998
aa3-N3 bound bovine 2.90 Å 1OCZ Yoshikawa et al., 1998
aa3 bovine
1.80 Å
1.80 Å
1V54
2DYR
Tsukihara et al., 2003
Muramoto et al., 2007
aa3-reduced bovine
1.90 Å
1.90 Å
1V55
2EIJ
Tsukihara et al., 2003
Muramoto et al., 2007
aa3-Cd2+ bound bovine 2.10 Å 2EIK, 2EIL Muramoto et al., 2007
aa3-Zn2+ bound bovine 2.70 Å 2EIM, 2EIN Muramoto et al., 2007
aa3 P. denitrificans 2.80 Å - Iwata et al., 1995
aa3 P. denitrificans 2.70 Å 1AR1 Ostermeier et al., 1997
aa3 P. denitrificans 3.00 Å 1QLE Harrenga and Michel, 1999
aa3 Rh. sphaeroides 2.30 Å 1M56 Svensson-Ek et al., 2002
aa3-E286Q Rh. sphaeroides 3.00 Å 1M57 Svensson-Ek et al., 2002
aa3 Rh. sphaeroides 2.00 Å 2GSM Qin et al., 2006
ba3 Th. thermophilus 2.40 Å 1EHK Soulimane et al., 2000
ba3 Th. thermophilus 2.30 Å 1XME Hunsicker-Wang et al., 2005
bo3, quinol oxidase E. coli 3.50 Å 1FFT Abramson et al., 2000
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2.3.1 Subunit I
Subunit I is the largest and the most conserved (Saraste, 1990) subunit of CcO with a molecular
weight  of  about  60  kDa  (Table  2).  It  consists  of  12  transmembrane  helices  without  any  large
extramembrane domain (Fig. 5A, shown in yellow). The helices are not perpendicular to the
membrane plane but tilted about 20-35o with respect to the membrane normal. When viewed
from  the  top  (P-side),  the  12  segments  of  subunit  I  form  three  semicircular  arcs  twisted
anticlockwise, and arranged around a quasi-threefold axis of symmetry (Fig. 5B). Three pores
(pores A, B, and C) are formed in the center of the arcs. Pore B houses the binuclear center (heme
a3 and  CuB) of the oxidase and includes the proton conductive K-channel that connects the
binuclear center with the N-side of the membrane (see below). Pore C retains heme a; the
remaining pore, A contains no cofactors but is the location of the proton conductive D-channel as
well as a plausible pathway for oxygen delivery to the binuclear site (Riistama et al., 1996).
Heme a is located in pore C at a depth of about 1/3 of the membrane thickness from the P-side
and is oriented perpendicular to the membrane plane such that its propionates are pointing
towards the P-side of the membrane. In both reduced (S=0) and oxidized (S=1/2) states (Tweedle
et al., 1978; Babcock et al., 1981) the heme iron is bound to four nitrogens of the porphyrin ring
and to two conserved histidines of subunit I.  The latter two histidine axial ligands of heme a:
HisI 94(61) and HisI413(378) are located in helices II and X respectively (Shapleigh et al., 1992;
Iwata et al., 1995; Tsukihara et al., 1995); the bonds between the histidines and the heme iron
hold the heme in the protein.
Biosynthesis of heme A is a sequential process (Fig. 4) that involves initial farnesylation of
protoheme (heme B) at the 2-position (Saiki et al., 1993) to form heme O. In the next step, the
heme O product is modified by hydroxylation of the methyl group at 8-position of the porphyrin
ring to formyl (Caughey et al., 1975).
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Figure 5. The structure of cytochrome c oxidase from P. denitrificans (PDB entry 1AR1). A.
Organization of subunits and redox-active centers: subunit I is shown in yellow, subunit II in red,
subunit III in pink, subunit IV in ice blue; hemes and coppers are shown in black (heme a3 on the
left and heme a on  the  right  side). B. Top view of subunit I; only metal centers and
transmembrane helices are shown. Helices form three semicircular arcs denoted A (orange), B
(green), and C (blue).
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The low-spin hemes in terminal oxidases are responsible for most absorption in the visible part
of the spectrum. The decomposed oxidized spectrum of heme a has peaks at 426 nm (e ~ 120
mM-1cm-1,  Soret  band)  and  595  nm  (e ~ 19.5 mM-1cm-1, alpha band) (Vanneste, 1966).
Absorption properties of heme a depend on the reduction state of the heme, making this center
an easy target for optical spectroscopy. The reduced -minus- oxidized  difference  spectrum  of
heme a, produced by the ligand-binding method introduced by Horie and Morrison (1963),  has a
peak at 445 nm (e ~ 57 mM-1cm-1), and a trough at 425 nm (e ~ -41mM-1cm-1) in the Soret
region  as  well  as  another  peak  at  605  nm  (e ~ 20.5 mM-1cm-1) in the alpha region (Vanneste,
1966). The absorption maximum at 605 nm in the reduced -minus- oxidized spectrum of heme a
in CcO is quite unusual for low-spin A-type heme (Lemberg, 1962). This maximum is red
shifted by about 15 nm compared to an isolated bis-imidazole heme A model compound
(Callahan and Babcock, 1983) due to formation of a strong hydrogen bond between the formyl
group of heme a and the neighboring ArgI54(38) (Kannt et al., 1999; Riistama et al., 2000b).
The second A-type heme is situated at about 13 Å (center-to-center distance) from heme a and is
denoted as a3. The plane of heme a3 is also perpendicular to the membrane and its propionates
point towards the P-side in a manner similar to heme a. The two hemes face each other at an
angle of 104-108° (Iwata et al, 1995; Tsukihara et al., 1995). Heme a3 is a high-spin heme in
both the fully-reduced ferrous state (S=2) (Babcock et al., 1976) and the resting ferric state
(S=5/2) (Babcock et al., 1981). Depending on conditions, heme a3 can be five- or six- coordinated
(Babcock et al., 1981): the permanent bonds of the heme iron include four bonds with nitrogens
of  the  porphyrin  ring  and  one  extra  bond with  the  conserved  HisI411(376) (Stevens and Chan,
1981; Shapleigh et al., 1992; Iwata et al., 1995; Tsukihara et al., 1995) that fixes the heme in the
protein. This five-fold coordination of the heme iron leaves one side of the heme empty and
available for binding of ligands such as dioxygen, carbon monoxide, azide, hydroxide ions, water
molecules etc. The binding of ligands can modulate the spin state of this heme: for example,
binding of cyanide to the ferric form changes the spin-state of heme a3 from high to low (S=1/2)
(Babcock et al., 1981).
The absolute absorption spectrum of oxidized heme a3 has a highly pronounced maximum in the
Soret region at 414 nm (e ~ 81 mM-1cm-1) and low intensity bands in the alpha region including
a maximum at around 600 nm and a beta-band at around 560 nm (Vanneste, 1966). The main
absorption changes in the reduced -minus- oxidized spectrum of heme a3 also correspond to the
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Soret region – peak at 444 nm (e ~112 mM-1cm-1) and trough at 411 nm (e ?? -50 mM-1cm-1),
whereas the absorbance in the alpha region is much less pronounced with a single peak at around
601 nm (e ? ~? 4.9 mM-1cm-1) and a shoulder at around 579 nm (e ~? 3.9 mM-1cm-1) (Vanneste,
1966; Liao and Palmer, 1996). In addition, oxidized heme a3 has one extra band, detected at
around 655 nm (charge-transfer band) attributed to charge-transfer to a ligand of heme a3
(Beinert et al., 1976; Shaw et al., 1978; Mitchell et al., 1991).
The  last  redox  metal  center  of  subunit  I  is  ~5  Å  away  from  heme a3 iron  and  is  formed  by  a
copper atom denoted as CuB. Together, heme a3 and CuB form the binuclear catalytic center of
the oxidase (Fig. 6), where all the chemistry of dioxygen splitting and reduction to water takes
place. The distance between the heme a3 iron and CuB seems to be the same in both reduced and
oxidized states of the enzyme (Harrenga and Michel, 1999) or fluctuates slightly in a range of
about 0.1-0.3 Å (Yoshikawa et al., 1998; Tsukihara et al., 2003). The oxidized CuB is  a
tetragonal center (Fann et al., 1995); it has three permanent histidine imidazole ligands,
identified by both genetic (Hosler et al., 1993) and X-ray spectroscopic approaches (Iwata et al.,
1995; Tsukihara et al., 1995; Ostermeier et al., 1997), as well as one mobile oxygen ligand with
exchangeable proton/protons (Fann et al., 1995). The imidazole ligands originate from
HisI276(240) in helix VI, and from HisI325(290) and HisI326(291) both located in the loop
between helices VII and VIII.
Due to an extremely low extinction coefficient, the absorbance spectrum of CuB is still unknown,
though it is possible to obtain information about the redox state of this center by optical
spectroscopy. Existing data indicate that the appearance of the charge-transfer band (655 nm)
requires both components of the binuclear center to be in the oxidized state; so reduction of CuB,
when heme a3 is oxidized, will induce decay in the intensity of the charge-transfer band (Beinert
et al., 1976; Mitchell et al., 1991). The other technique that can be used to observe the CuB
center is electron paramagnetic resonance (EPR) which spectroscopy is sensitive to molecules
and ions with unpaired electron spins. Since in the oxidized (cupric) state the copper atom
contains  one  unpaired  electron  in  the  highest  orbital,  in  theory  the  redox  state  of  CuB can be
followed  by  EPR.  Unfortunately,  the  presence  of  the  heme a3 iron in proximity to the copper
atom results in a strong antiferromagnetic interaction between these two centers making them
both EPR silent (van Gelder and Beinert, 1969) in most situations. Only when one or the other of
them is reduced, or the magnetic coupling has been broken by other means, does the EPR signal
from the oxidized center appear. For example, in a reaction of the fully-reduced CcO with
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dioxygen done at low-temperature (Reinhammar et al., 1980; Karlsson and Andreasson, 1981;
Karlsson et al., 1981; Blair et al., 1985; Morgan et al., 2001), or by decoupling of the heme a3-
CuB pair using techniques including: ligand binding, gamma radiation, saturated ammonium
sulfate treatment, incubation in some detergents, etc. (Pezeshk et al., 2001). The EPR signal of
CuB exhibits the four characteristic hyperfine peaks of a type 2 cupric center and is centered near
g = 2.25.
Another important structure identified in CcO consists in the covalent bond between
HisI276(240) and TyrI280(244) (Fig. 6). Because of this connection the 3 histidines and the
tyrosine form a conjugated p-electron system around the CuB center.  In  addition  to
crystallographic studies, the existence of the histidine-tyrosine cross-link was also confirmed by
protein sequencing and mass-spectroscopic analysis of CcO from several species (Buse et al.,
1999; Rauhamäki et al., 2006). Formation of this bond could considerably reduce the pKa of the
tyrosine (Yoshikawa et at., 1998; McCauley et al., 2000), allowing it to participate in the oxygen
reduction process by donating both the proton and the fourth electron required for the reaction,
and forming a tyrosine radical (Proshlyakov et al., 1998; Proshlyakov et al, 2000).
Figure 6. Catalytic center of cytochrome c oxidase (PDB entry 1V54): high-spin heme a3, CuB,
histidine-tyrosine cross-linked structure, and their ligands. Amino-acid numbering from P.
denitrificans / bovine enzymes.
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In addition to the redox-active centers, subunit I also contains tightly bound non-redox active
metal  centers.  A  Mg2+/Mn2+ binding site is located at the interface between subunits I and II,
approximately half way between the heme a3 and  CuA centers. The metal atom is ligated to
HisI403(368), AspI404(369), GluII198(218), and to three water molecules (Hosler et al., 1995;
Ostermeier et al., 1997; Tsukihara et al., 1995; Yoshikawa et al., 1998; Svensson-Ek et al.,
2002). In mitochondrial CcO this site is occupied by magnesium (Einarsdóttir and Caughey,
1985; Tsukihara et al., 1995), whereas in bacterial oxidases it can be partially substituted by a
manganese atom (Seelig et al., 1981). The function of this metal site is unknown, but it was
shown  that  Mn2+ is located in the expulsion pathway for the waters that are produced in the
binuclear center of the oxidase (Schmidt et al., 2003). Site-specific mutagenesis of the metal-
ligating residues did not cause either a change in pumping efficiency or a significant decrease in
the enzymatic activity (Hosler et al., 1995; Fetter et al., 1995). In addition, proton-translocating
quinol oxidases lack this center (Abramson et al., 2000) without any effect on the proton
translocation ratio (Puustinen et al., 1989; Verkhovskaya et al., 1992). However, since both
subunits I and II have a number of negatively charged residues at their common interface, the
Mg2+/Mn2+ site may be important for their stabilization.
Another non-redox active metal site has been found in a loop between helices I and II close to
the P-side of the membrane. The identity of the metal ion in this center is not completely clear:
based on ligand coordination pattern it has been predicted to be occupied by sodium in
mitochondrial oxidases (Yoshikawa et al., 1998) and by calcium in bacterial ones (Ostermeier et
al., 1997; Svensson-Ek et al., 2002). At the same time, cation-binding experiments suggest that
in the mitochondrial CcO this site can reversibly bind either calcium or sodium (Kirichenko et
al., 1998), whereas in bacterial oxidases this site contains only a tightly bound calcium that
cannot be removed even by an excess of chelating agents such as EGTA (ethyleneglycol-bis-(b-
aminoethyl either)N,N’-tetra-acetic acid) (Riistama et al., 1999; Pfitzner et al., 1999; Lee et al.,
2002). The role of the tightly bound Ca2+ may be in structural stabilization of the bacterial
oxidases (Lee et al., 2002).
2.3.2 Subunit II
Subunit  II  is  another  CcO  subunit,  which  contains  redox  active  cofactors.  It  has  a  molecular
weight of about 27 kDa (Table 2), and forms two transmembrane helices interacting with subunit
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I (Figure 5A) and a large C-terminal hydrophilic globular domain at the P-side of the membrane
(Iwata et al., 1995; Tsukihara et al., 1996). The redox active copper center, conventionally
referred to as CuA, is formed by two copper atoms. There has been a long discussion in the
oxidase field concerning the type and number of copper atoms in the CuA center and only at the
beginning of the 1990s this issue was finally resolved (Kroneck et al., 1990; van der Oost et al.,
1992; Antholine et al., 1992; Malmström and Aasa, 1993; Kelly et al., 1993; Lappalainen et al.,
1993). The CuA center  in  the  oxidized  state  of  the  enzyme  was  found  to  be  in  mixed-valence
configuration that can be formally represented as [Cu1.5+-Cu1.5+]. Upon reduction CuA holds an
electron by sharing it between both copper atoms. This redox center is situated in the globular
domain almost on the border with subunit I. As was shown by site-directed mutagenesis (Kelly
et al., 1993) and confirmed later by X-ray crystallography (Iwata et al., 1995; Tsukihara et al.,
1995), CuA is ligated to two cysteines (CysII216(196) and CysII220(200)), two histidines
Table 2. Subunit composition of terminal oxidases in mitochondria and bacteria.
bovine (heart) aa3 P. denitrificans aa3
Subunit1
Mr2 composition
encoded
by
Mr3 composition
I 56993 12 a-helices mitochondria 62500 12 a-helices
II 26049 2 a-helices mitochondria 27999 2 a-helices
III 29918 7 a-helices mitochondria 30671 7 a-helices
IV 17153 1 a-helix nucleus 5364 1 a-helix
Va 12434 at the N-side nucleus
Vb 10670 at the N-side nucleus
VIa 9418 1 a-helix nucleus
VIb 10068 at the P-side nucleus
VIc 8480 1 a-helix nucleus
VIIa 6234 1 a-helix nucleus
VIIb 6350 1 a-helix nucleus
VIIc 5541 1 a-helix nucleus
VIII 4962 1 a-helix nucleus
1 Mitochondrial subunit nomenclature from Kadenbach and Merle, 1981;
2 Molecular masses for bovine aa3 from Capaldi, 1990;
3 Haltia et al., 1994; Witt and Ludwig, 1997.
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(HisII181(161) and HisII224(204)), one methionine (MetII227(207)) and one carbonyl oxygen of
GluII218(198).
The  redox  state  of  CuA can  be  followed  by  optical  absorbance  spectroscopy.  The  spectrum  of
oxidized CuA has two clear maxima: a broad peak at around 820 nm (e ~? 1.6 mM-1cm-1)  and  a
rather sharp peak at 480 nm (e ~? 3.0 mM-1cm-1) with a shoulder at about 530 nm (Lappalainen et
al., 1993; Jasaitis et al., 2001). Even though the extinction coefficient of the latter peak is higher,
the practical characteristic wavelength of CuA in the intact CcO is in the region of around 820
nm, where hemes do not absorb, thus making it possible to follow redox changes of CuA only. In
addition to optical absorbance spectroscopy, the EPR technique has proved to be a valuable tool
for studies of CuA.  Oxidized CuA possesses a strong and characteristic EPR signal in the g ~ 2
region (Beinert et al., 1962; Aasa et al., 1976) measured at the temperature of liquid nitrogen and
lower.
2.3.3 Subunit III
Subunit III is the biggest subunit of CcO (Fig. 5A) that has no redox cofactors. It has a molecular
weight of about 30 kDa (Table 2), and consists of seven transmembrane helices without any
extensive extramembrane domain. The helices of subunit III are arranged into two bundles: the
first one is formed by helices I and II, and the other by helices from III to VII (Iwata et al., 1995;
Tsukihara et al., 1996). The bundles of helices are tilted with respect to each other forming a
large V-shaped cleft joined at the N-side of the membrane. Subunit III is in side-to-side contact
with the helices of pore A of subunit I.
The function of this subunit is unknown: it contains no prosthetic groups, and, it is not involved
in proton pumping as shown using a two-subunit enzyme preparation from P. denitrificans
reconstituted into liposomes (Solioz et al., 1982; Hendler et al., 1991) and by a mutagenesis
study (Haltia et al., 1991). However, it might be involved in the stabilization of the mature
oxidase and in ensuring correct assembly of the enzyme (especially at the final folding step of
subunit I), including structural adjustment of the heme centers (Haltia et al., 1989). At the same
time, the V-shaped cleft is located at the mouth of the oxygen conducting channel and may
secure a constant flux of oxygen into the catalytic center (Riistama et al., 1996, see below). It is
also possible that the membrane-anchored cytochrome c552, which is a physiological electron
donor for CcO from P. denitrificans (Berry and Trumpower, 1985), might use this cleft for
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binding and placing itself in an appropriate position for electron transfer to CuA (Iwata et al.,
1995).
2.3.4 Other Subunits
In addition to the three core subunits, heme-copper terminal oxidases can have extra subunits.
CcO from P. denitrificans has one additional subunit (Haltia et al., 1994; Iwata et al., 1995) with
a molecular weight of about 5 kDa (Witt and Ludwig, 1997). It has one transmembrane helix,
which is in contact with all other subunits. The function of this subunit is unknown: deletion of
its gene has no effect on either protein integrity or enzymatic and spectral properties of the
oxidase (Witt and Ludwig, 1997).
In mammalian CcO the three mitochondrially-encoded core subunits (homologous to the three
main subunits of the bacterial enzyme) are supplemented by ten additional subunits, which are
encoded by nuclear DNA (Table 2). Seven out of ten nuclear encoded subunits consist of one
transmembrane helix each, whereas subunits Va, Vb and VIb are small globular proteins.
Subunits Va and Vb are bound to the oxidase on the matrix side of the protein, while subunit VIb
is bound on the intermembrane side. Because none of the nuclear encoded subunits are
associated with the active site, it is quite unlikely that they are important in the functional
mechanism of CcO. However based on the fact that binding sites for ATP/ADP (Tsukihara et al.,
1996; Kadenbach et al., 2000), protein kinase A (Yang et al., 1998), and 3,5-diiodothyronine
(Arnold et al., 1998) have been found within some of them, it has been assumed that the nuclear
encoded subunits have a regulatory function. The role of these subunits in the regulation of the
enzymatic activity is also supported by the presence of tissue-specific isoforms in mammals
(Kadenbach et al., 2000). Studies on yeast subunit VIb, which exhibits high amino acid sequence
identity to bovine CcO, show that this subunit can be important during assembly of the oxidase,
though it can be removed from the mature enzyme without any effect on activity (LaMarche et
al., 1992). The crystal structure of bovine CcO indicates that subunits VIa and VIb might be
involved in stabilization of a dimer state of the protein (Tsukihara et al., 1996). In addition,
mitochondrial oxidase contains Zn2+, which is tightly bound to subunit Vb (Tsukihara et al.,
1995&1996).
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2.4 Pathways
The chemical reaction of oxygen reduction to water, which triggers proton translocation across
the membrane, occurs at the binuclear center in the middle of the protein and requires both
delivery of substrates (i.e. electrons,  protons,  and  oxygen)  and  release  of  products  (water).  All
these aforementioned reactants, which are necessary for the functioning of the oxidase, are
transported to the catalytic site through specialized pathways. These pathways have been
identified and they can be divided into electron-, proton- and oxygen- transfer structures.
2.4.1 Electron-transfer Pathways
The transfer of electrons within proteins is a quite complicated process defined by a number of
factors. According to electron-transfer theory (Marcus and Sutin, 1985) the rate of electron
transfer depends on the distance between donor and acceptor, the difference in their redox
potentials, and the reorganization energy (i.e. the energy required to alter the equilibrium
geometry of the initial state into the equilibrium geometry of the product). There are two main
theories to describe the mechanism how the electron is transferred within a protein. In the first
conceptualization (Gray and Winkler, 1996), electron tunneling is considered to occur
specifically through bonds and can be modulated by conformational changes of the secondary
structure of the protein. In contrast, the other theory (Moser et al., 1992; Page et al., 1999)
postulates that efficient tunneling of electrons is not limited to any specially designed pathway
within the protein, but rather occurs via multiple pathways through the protein medium; and in
the simplest view it can be defined by edge-to-edge distance between donor and acceptor,
modified by atomic density of the intervening medium.
The reduction of dioxygen to water requires four electrons. These electrons are donated one by
one from water-soluble cytochrome c, which serves as one-electron mediator between the
cytochrome bc1-complex and CcO. Cytochrome c binds in a cleft between subunits II and III on
the P-side of the membrane (Fuller et al., 1981; Iwata et al., 1995). This area is enriched in
acidic residues (Iwata et al., 1995; Tsukihara et al., 1996) that could interact with positively
charged lysines and arginines on the surface of cytochrome c (Ferguson-Miller et al., 1978;
Rieder and Bosshard, 1980; Bushnell et al., 1990). Thus, it is likely that the formation of
cytochrome c – CcO complex is defined mostly by electrostatic interactions between the
proteins; this is also supported by the fact that there is a strong dependence of the reaction of
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reduced cytochrome c with the oxidase on the ionic strength of the medium (Antalis and Palmer,
1982; Hazzard et al., 1991; Witt et al., 1998; Zhen et al., 1999). However, it cannot be excluded
that complex formation is additionally modulated by hydrophobic forces (Pelletier and Kraut,
1992). As soon as cytochrome c binds to the oxidase, the electron is rapidly transferred via the
highly conserved TrpII121(104) (Witt et al., 1998; Zhen et al., 1999) to the primary electron
acceptor – the bimetallic copper center, CuA (Kobayashi et al., 1989; Hill, 1991). The rate of
electron transfer in this process has been found to be of the order of 0.6 - 1 × 105 s-1 (Hill, 1991;
Hill, 1994; Geren et al., 1995).
The CuA center is situated near the membrane surface on the P-side of the membrane, while all
other redox centers are buried at an equal depth, approximately 1/3 (13 Å) of the membrane
thickness below the membrane surface from the P-side (Iwata et al., 1995; Tsukihara et al.,
1995). The centre-to-centre distance between CuA and the iron atom of heme a is 19.5 Å and this
is  only  2.6  Å  closer  than  the  distance  between  CuA and  the  iron  atom  of  heme a3 (22.1 Å).
However despite such similarity in distances, the preference in electron transfer from CuA is
completely biased towards heme a. The reason for this effect may be purely thermodynamic. The
electron transfer from CuA to heme a is not coupled to proton uptake to compensate the negative
charge at the heme a;  at  the  same  time,  the  midpoint  redox  potential  of  heme a3 without
protonation is far too low to permit electron transfer (Mitchell and Rich, 1994; Verkhovsky et
al., 2006); thus the rate of heme a3 reduction may be limited by slow proton uptake for charge
compensation (Verkhovsky et al., 1995; Brzezinski, 1996), thereby leading to the observed
results.
From electron injection experiments, the rate of electron equilibration between CuA and heme a
is estimated to be about 1.8 × 104 s-1 in mitochondrial (Kobayashi et al., 1989; Nilsson, 1992;
Zaslavsky et al, 1993; Winkler et al., 1995) and about 1.1 × 105 s-1 in bacterial oxidases
(Konstantinov et al., 1997; Zaslavsky et al., 1998; Verkhovsky et al., 2001b; Papers III&V). The
same equilibration, measured by perturbed equilibrium methods (see sections 4.1&5.2), has
similar rates for the mitochondrial enzyme (Morgan et al., 1989; Oliveberg and Malmström,
1991; Verkhovsky et al., 1992; Jasaitis et al., 1999), while in bacteria it seems to be three-four
fold slower ~ 2.8 × 104 s-1 (Ädelroth et al, 1995; Paper II).
Heme a serves as a donor of electrons to the heme a3-CuB center. The planes of the two hemes
are perpendicular to the membrane, forming an interplanar angle of 104-108o, with a minimal
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edge-to-edge distance between the hemes of about 4.7 Å (Iwata et al., 1995; Tsukihara et al.,
1995). The measured rate of electron equilibration between heme a and heme a3 varies
significantly,  depending  on  the  particular  circumstances  under  which  the  measurements  are
made. When the electron is delivered into the oxidized enzyme from reduced cytochrome c, the
equilibrium is reached with a time constant of the order 0.3 - 1.0 s (Antalis and Palmer, 1982);
alternatively, when fully-reduced oxidase reacts with dioxygen, electron equilibration is much
faster and has a time constant of about 30 ms (Hill, 1991; Verkhovsky et al., 1994). But the
fastest rate of electron equilibration between the hemes can be measured after CO
photodissociation from the mixed-valence (two-electron reduced) enzyme. In this case, a phase
with a time constant of 3-5 ms was identified and assigned to electron transfer from heme a3 to
heme a (Oliveberg and Malmström, 1991; Verkhovsky et al., 1992; Einarsdóttir et al., 1995;
Ädelroth et al, 1995). However the rate of this process is still at least three orders of magnitude
slower than predicted by electron transfer theory (Moser et al., 1992; Page et al., 1999), where
the expected time constant of electron tunneling between these two heme centers is estimated to
be in the nanosecond time domain. Recently, based on detailed analysis of the  “photolysis”
spectra of the CO-bound fully-reduced and mixed-valence states, measured with submicrosecond
time resolution, it was proposed that in mixed-valence state about 20% of heme a3 oxidation
occurs faster than 3 ms, and presumably faster than 40 ns (Verkhovsky et al., 2001a). Later this
proposal was confirmed by sensitive pump-probe transient absorbance spectroscopy with
femtosecond time resolution (Pilet et al., 2004). Thus, dissociation of CO from the binuclear
center induces an initial phase of ultra-fast electron equilibration between the hemes with a time
constant of about 1.2 ns, followed by a slower equilibration phase with a time constant of 3 ms,
which is possibly determined by the kinetics of CO dissociation from the CuB center
(Verkhovsky et al., 2001a; Pilet et al., 2004). Such a large magnitude of difference in the
observed rates of electron equilibration between the hemes is attributed to possible structural
rearrangement  of  the  protein,  or  to  coupling  of  electron  transfer  to  protonation  or  ligand  state
changes of neighboring groups (Verkhovsky et al., 1995; Brzezinski, 1996; Verkhovsky et al.,
2001a; Pilet et al., 2004).
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2.4.2 Proton-transfer Pathways
order to overcome this limitation the
oxidase has specialized proton-conductive
structures. It is proposed that these
structures are based on chains of hydrogen
bonds between hydrogen-bonding protein
side groups (polar and/or protonatable)
and water molecules, where the proton is
transferred by a Grotthuss type
mechanism (de Grotthuss, 1806&2006;
Nagle and Morowitz, 1978; Agmon,
1995). In this mechanism the excess
proton on a hydronium ion is transferred
to an acceptor water molecule by means
of O-H covalent bond breakage in the
donor molecule, and its reforming in the
acceptor as a result of proton exchange
between  these  two  molecules  (Fig.  7).  After  such  proton  hopping  from  donor  to  acceptor,  the
whole hydrogen-bonded chain is aligned in the wrong direction for further transfers and has to be
reoriented. Only after reorientation the next proton can be transferred in the same direction as the
previous one.
At least two proton-conductive channels have been identified by site-directed mutagenesis
(Hosler et al., 1993; Thomas et al., 1993ab; Fetter et al., 1995) and later confirmed by X-ray
spectroscopy (Iwata et al., 1995; Tsukihara et al., 1996; Abramson et al., 2001; Svensson-Ek et
al., 2002). Both channels are situated in subunit I and lead from the N-side of the membrane
towards the catalytic center of the oxidase (Fig. 8).
Since the redox centers of the oxidase are buried within the protein they have no direct contact
with the aqueous phase. However, maintenance of high rates of respiration requires both fast
proton delivery to the catalytic center and corresponding fast proton translocation across the
membrane. It should be noted that the proton transfer pathways in CcO have been much less
investigated than the electron transfer pathways. The unstructured protein medium itself cannot
facilitate efficient proton delivery towards the binuclear center, or across the membrane, and in
Figure 7. Schematics of the Grotthuss mechanism.
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Figure 8. Proton conducting pathways together with the redox centers heme a, heme a3, and CuB
in cytochrome c oxidase (PDB entry 1AR1). The red spheres are structurally identified water
molecules (based on the bovine 1V54 x-ray structure). P. denitrificans amino-acid numbering.
One of these is the K-pathway, named after the highly conserved lysine 354I(319) (Hosler et al.,
1993; Thomas et al., 1993b), which is situated approximately halfway through the channel. This
pathway starts with either SerI291(255) (Iwata et al., 1995; Tsukihara et al., 1996) or GluII78(62)
(Kannt et al., 1998; Ma et al., 1999; Brändén et al., 2002) and continues through conserved
residues LysI354(319), ThrI351(316), towards the hydroxyethyl farnesyl side chain of heme a3
and TyrI280(244), in the proximity to the binuclear center. TyrI280 at the end of the K-pathway
is covalently linked to HisI276(240) by post-translational modification, and is assumed to be
involved in oxygen reduction catalysis. The importance of TyrI280 is supported by site-directed
mutagenesis studies, in which all mutational substitutions for this tyrosine result in complete
elimination of oxidase activity (Hosler et al., 1993; Thomas et al., 1994; Pfitzner et al., 1998).
Two or three tightly bound water molecules can be found in this pathway in the X-ray structures.
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One water molecule is situated between ThrI351 and the hydroxyl group of the hydroxyethyl
farnesyl side chain of heme a3, another between SerI291 and LysI354, and finally a possible third
between GluII78 and LysI354 (in 1V54, 1V55, Table 1). The amino acid residues of the K-
pathway are connected by hydrogen bonds; however this connection seems to be interrupted by a
large hydrophobic gap between LysI354 and ThrI351, where no water molecules have been
found so far. It is proposed that this gap might be bridged by a movement of lysine residue
(Hofacker and Schulten, 1998).
The other channel, named D after the highly conserved AspI124(91) (Thomas et al., 1993a;
Fetter et al., 1995; Pfitzner et al., 1998), that is situated near the surface of the enzyme on the N-
side. AspI124 together with ThrI203(167) and AsnI199(163) form a mouth that leads via polar
residues AsnI113(80), AsnI131(98), TyrI35(19), SerI134(101), SerI192(156), SerI193(157) and
crystallographically identified bound water molecules to GluI278(242), which is an important
residue for proton pumping (Svensson-Ek et al., 1996; Ädelroth et al., 1997; Verkhovskaya et
al., 1997; Konstantinov et al., 1997). The mode of proton translocation after GluI278 is not clear
because no proton connectivity beyond this residue has been detected in the crystallographic
structures. However, it is proposed that this space is occupied by three to four mobile water
molecules (Riistama et al., 1997; Zheng et al., 2003) that form a proton conductive pathway
directing protons either to the D-propionate of heme a3 for pumping or to the binuclear center for
water formation (Hofacker and Schulten, 1998; Wikström et al., 2003). Release of the pumped
proton takes place through the highly hydrophilic domain above the heme groups. This area
contains an extended hydrogen-bonded network of charged and polar amino acid residues, the
propionates of the hemes, bound metal centers and water molecules, and presumably is involved
in the transfer of pumped protons towards the P-side of the membrane (Iwata et al., 1995;
Tsukihara et al., 1996; Ostermeier et al., 1997). Based on results of site-directed mutagenesis
studies it is believed that the exit channel for pumped protons may start at the conserved residues
ArgI473(438) and ArgI474(439) (Puustinen and Wikström, 1999; Brändén et al., 2005), which
are hydrogen-bonded to the D-propionates of the hemes, and then continue through the chains of
mobile water molecules.
The presence of two independent proton conducting pathways in the oxidase was suggested
immediately after the discovery of proton pumping (Wikström et al., 1977; Artzatbanov et al.,
1978). The initial hypothesis was appealingly simple: the presence of two channels in the
oxidase  was  explained  in  terms  of  a  different  role  for  each  channel  in  the  proton  transfer
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mechanism. It was proposed that the D-channel is responsible for translocation of “pumped”
protons, while the K-channel is used for uptake of “chemical” protons for water formation.
However, this idea turned out to be incorrect, and more recent results have indicated more
complicated mechanism. The D-channel is involved in the transfer of all four “pumped” protons
and two “chemical” protons used in the oxidative part of the catalytic cycle (Konstantinov et al.,
1997; Ädelroth et al., 1997), while the K-channel is responsible for the uptake of another two
“chemical” protons during the reductive part of the cycle (Hosler et al., 1996; Konstantinov et
al., 1997; Ädelroth et al., 1998a; Wikström et al., 2000; Paper III). In addition, LysI354 may also
be involved in the oxidative part of the cycle (Brändén et al. 2001) providing charge
compensation upon electron transfer from heme a to the binuclear site and formation of the P
intermediate.
Interestingly, based on structural analysis of bovine heart CcO in the reduced and oxidized
states, one additional proton-conductive pathway has been proposed (Tsukihara et al., 1996;
Yoshikawa et al., 1998). This so-called H-channel, named after the partially conserved residue
HisI413bovine,  begins  at  the  N-side  of  the  membrane  and  leads  to  AspI51bovine on the P-side.
Depending on the reduction state of heme a, AspI51bovine changes its conformation from protonic
equilibrium with the matrix space, when heme a is oxidized, to equilibrium with the
intermembrane space when heme a is reduced, providing a gate for proton translocation across
the membrane. Replacements, using a bovine gene expression system, of amino acid residues
involved in the formation of this channel (like AspI51 to asparagine) abolish pumping without
impairment of catalytic activity (Tsukihara et al., 2003). However, it seems that this channel (if it
exists) is strictly a property of mammalian oxidases, since bacterial oxidases lack some of the
key residues involved in its formation, and extensive mutations of other residues in the proposed
area have shown no functional significance for proton translocation (Pfitzner et al., 1998; Lee et
al., 2000). Thus, either the mechanism of proton pumping in the mammalian CcO is different
from the bacterial one, which seems quite unlikely due to their similar properties and structures,
or the H-channel has another function, for example charge compensation upon heme a reduction.
2.4.3 Oxygen-transfer Pathways
As a small, uncharged molecule, dioxygen can easily permeate membranes and on a first sight
should be able to reach the catalytic site of the oxidase even without any specific route, through
loosely packed regions, using conformational fluctuations of the protein. However, the rate of
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such uncontrolled diffusion is slow, and most likely insufficient to maintain normal catalytic
activity of the oxidase. Thus, the protein must have certain structures that function as channels
for oxygen delivery to the reaction center. And indeed, analysis X-ray crystal structures
(Tsukihara et al., 1996; Svensson-Ek et al., 2002), supplemented by experimental (Riistama et
al., 1996&2000a; Salomonsson et al., 2004) and theoretical examinations (Hofacker and
Schulten,  1998),  reveals from one (in P. denitrificans) to three (in bovine) highly hydrophobic
passages from the middle of the membrane bilayer, where oxygen is concentrated, towards the
active site. Interestingly, even a single amino-acid mutation can dramatically influence the
binding of oxygen, causing partial (in ValI279 to isoleucine mutant, Riistama et al.,
1996&2000a) or even complete inhibition (in GlyI283 to valine mutant of R. sphaeroides,
Salomonsson et al., 2004).
2.5 Intermediates of the Catalytic Cycle
In contrast to most cell proteins, the redox centers of CcO are colored and characterized by
distinct optical spectra in oxidized and reduced states, and mainly because of this our basic
description of the intermediates of the catalytic cycle was obtained by optical absorbance
spectroscopy. At the same time, for a deeper understanding of internal processes in the catalytic
cycle the optical studies must often be supplemented with other measurements, such as
resonance Raman studies of intermediates, determination of potential generation across the
membrane, measurements of proton uptake and release, etc.
Approximately up to ten intermediates of the catalytic cycle have been identified (Fig. 9); some
of them are more or less stable, while the others appear only for a fraction of a millisecond. It
should be noted that the letter abbreviations accepted in the literature for the different states
reflect only the state of the binuclear site and do not specify the redox states of heme a and CuA.
Fully oxidized O-state. The enzyme after purification is in the fully-oxidized “as prepared” state,
where all redox centers of the protein are oxidized and the enzyme cannot react with dioxygen.
Sometimes, depending on the details of the purification protocol, it may contain a subpopulation
in the E (one-electron reduced) state. The enzyme in the O state is often includes populations of
different substates that differ with respect to the ligation state of the high-spin heme. These
substates can roughly be divided into two groups based on their ability to react with cyanide
(Baker et al., 1987; Moody et al., 1991a). One - the “slow” form has a maximum in the Soret
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region below 418 nm and is characterized by slow kinetics of cyanide binding to the oxidized
heme a3. The absorbance maximum of the other - “fast” - is several nanometers red-shifted; this
form binds cyanide at least 100-fold more rapidly. The enzyme in the “slow” form can be
obtained when the protein is incubated or purified in a low pH buffer (~6), especially in the
presence of certain anions such as Br-, HCOO-, or Cl- (Baker et al., 1987; Moody et al., 1991a).
At the same time, the fully-oxidized “as prepared” state is often referred to as the “resting” form
of the oxidase, and it can include both “slow” and “fast” forms. Reduction and re-oxidation
(pulsing) of the “resting” oxidase produces the homogeneous population of the oxidized O state
– the so-called “oxygen pulsed” form (Antonini et al., 1977). The “pulsed” form is highly active
and has properties very similar to the “fast” form, though most likely these forms represent
different states of the enzyme discriminated by their ability to pump protons upon reduction
(Verkhovsky et al., 1999b; Paper III&V). Thus, the “pulsed” form is probably the same state as
the OH intermediate in the catalytic cycle (see below).
Figure 9. The catalytic cycle of cytochrome c oxidase supplemented with plausible structures of
the intermediates. The definitive structure of the F state is still unclear and two possible
configurations may be proposed.
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One-electron reduced E-state. In the E state an electron is shared between heme a3 and CuB in
the binuclear center. This state can be obtained in potentiometric titrations where it is
characterized by the presence of a g = 6 EPR signal. This signal originates from the oxidized
high-spin heme a3 (when CuB is reduced) and the maximal amplitude of the g = 6 EPR signal
(Wilson et al., 1976) in a potentiometric redox titration would indicate maximal yield of the E
state. Alternatively, it is possible to create E by several kinetic techniques such as flash-induced
chemical photoreduction (FIRE) (Moody et al., 1991b), or electron injection from RubiPy
(Nilsson, 1992; Ruitenberg et al., 2000; Verkhovsky et al., 2001b). However it should be
stressed that formation of the E state by the kinetic techniques takes seconds, due to extremely
slow proton uptake to the binuclear center for charge compensation. Taking into account that the
complete cycle of CcO occurs in a few milliseconds, it is rather unlikely that the E state  is  a
natural state during catalytic turnover of the oxidase. Unlike hemoglobin or myoglobin one
electron reduced CcO cannot bind either oxygen or carbon monoxide (Lindsay et al., 1975;
Malatesta et al., 1990).
Reduced R-state. The R state is the state which is capable of dioxygen binding and can have
from 2 to 4 electrons in the redox centers. Delivery of an electron alone into low dielectric media
deep in the middle of the membrane, where three out of four enzyme redox centers are located, is
energetically unfavorable, but can be enhanced when coupled with proton uptake. Indeed,
Mitchell and Rich (1994) based on experimental determination of proton uptake upon reduction
and binding of anions (azide, formate, fluoride, or cyanide) suggested an “electroneutrality
principle”, which postulates that reduction of the binuclear center is coupled to uptake of two
protons for charge compensation. Complete reduction of the oxidase by 4 electrons is coupled to
uptake of 2.1-2.4 H+/CcO in R. sphaeroides and bovine oxidases (Mitchell & Rich, 1994;
Capitanio et al., 1997; Ädelroth et al., 1998b). At least two of these protons are taken up via the
K-pathway and most likely are used for water formation (Hosler et al., 1996; Konstantinov et al.,
1997; Ädelroth et al., 1998a; Wikström et al., 2000; Paper III). Both fully-reduced and mixed-
valence (two-electron reduced) oxidases can bind CO to heme a3. Binding of CO to the binuclear
center increases midpoint potentials of heme a3 and  CuB, and stabilizes their reduced form
(Wilson  & Nelson,  1982).  Depending  on  the  reduction  level  of  the  oxidase,  two types  of  CO-
bound compounds are defined: the fully-reduced CO-bound (COFR) form with all four redox
centers in the reduced state and the mixed-valenced CO-bound (COMV) form, where only a3 and
CuB are reduced. Both forms, COFR and COMV, are widely used as starting points for studies of
intermediates in the reaction cycle.
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Ferrous-oxy A intermediate. As mentioned in the previous paragraph, the oxidase in the two-
electron reduced state can already react rapidly with dioxygen producing the so-called compound
A. Compound A is the first spectroscopically detectable intermediate, originally reported by
Chance et al. (1975) in their low-temperature “triple-trapping” experiments, with a 591 nm peak
and a 611 nm trough in the difference (A -minus- R) spectrum. At room temperature compound
A is formed with a time constant of 8 ms at 1 mM oxygen concentration (Oliveberg et al., 1989;
Verkhovsky et al., 1994) and has an absorbance maximum in the difference spectrum at 595 nm
(Hill & Greenwood, 1983; Verkhovsky et al., 1996a; Sucheta et al.,  1998).  Similar  to
oxyhemoglobin and oxymyoglobin, the Raman spectrum of compound A (Varotsis et al., 1989;
Han et al., 1990a) has a stretching mode at 568 cm-1 which characterizes the 2
2
a OFe 3 -
+  structure
of the binuclear center.
Peroxy intermediate, PM. Compound A is unstable and in the case of the mixed-valence enzyme
decays with t ~150 ms (Hill & Greenwood, 1983; Oliveberg et al., 1989) into the so-called
peroxy (PM)4 intermediate, originally named compound C (Chance et al., 1975). This
intermediate is stable and the reaction stops here unless an additional electron enters the enzyme.
This compound was named “peroxy” because it was thought that the oxygen-oxygen bond was
still intact, and heme a3 had a peroxy structure --3a O-OFe 3 -
+ . But more recent examination by
time-resolved resonance Raman (Proshlyakov et al., 1998), and mass-spectrometry (Fabian et
al., 1999) clearly demonstrated that the oxygen-oxygen bond is already broken, and that heme a3
is in the oxo-ferryl state ( OFe4a3 =
+ ) with the other oxygen atom, spatially derived from O2,
bound to CuB as a hydroxide ion. The PM state can also be formed directly in the reaction of the
oxidized CcO at alkaline pH with stoichiometric amounts of H2O2 (Bickar et al., 1982;
Wrigglesworth, 1984; Vygodina & Konstantinov, 1989), where the resulting spectrum has
characteristic peaks at 607 (e607-e630 ~ 11 mM-1·cm-1) and 570 nm in the PM-minus-O difference
spectrum. Cleavage of the O-O bond requires simultaneous transfer of four electrons to the
molecule of dioxygen. Three of these electrons are donated from the metals of the binuclear
center: one from CuB (CuB+?CuB2+) and two from the heme a3 iron  ( +2a3Fe ?
+4
a3
Fe ), while the
source of the fourth electron is still under debate. Presumably, the fourth electron is donated
from one of the amino-acid residues in the proximity of the catalytic site. High-resolution X-ray
crystallographic structures (Yoshikawa at al., 1998; Ostermeier et al., 1997) and biochemical
4 Subscripts ‘M’/‘R’ in P were introduced to distinguish the origins of two peroxy-oxygen intermediate forms: mixed-
valence and fully-reduced, respectively.
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analysis (Buse et al.,  1999)  have  revealed  that  the  conserved  residue  TyrI280(244), in the
catalytic center, is covalently linked (Fig. 6) to one of the ligands of CuB (HisI276(240)). It has
therefore  been  proposed  to  serve  as  a  source  of  the  remaining  electron.  In  addition  to  electron
transfer,  O-O  bond  cleavage  requires  delivery  of  a  proton.  The  reaction  of  COMV  with  O2
occurs without external proton uptake (Oliveberg et al., 1991), indicating that the required
proton must be borrowed from one of the groups within the oxidase. At the same time,
electrometric results show virtually no phase of potential generation upon the R?PM reaction
(Jasaitis et al., 1999); thus it is most likely that the required proton is taken from a group which
is very close to the catalytic center. Taken together, these findings suggest that it is reasonable to
propose that TyrI280 provides both an electron and a proton for O-O bond splitting, producing a
neutral tyrosine radical (Proshlyakov et al., 1998; Proshlyakov et al, 2000).
Peroxy intermediate, PR. When the oxygen reacts with the fully-reduced oxidase, compound A
relaxes in about 30-40 ms (Oliveberg et al., 1989; Verkhovsky et al., 1994) into another unstable
peroxy intermediate (PR). As was shown by optical absorbance (Hill 1991; 1994) and resonance
Raman spectroscopy (Han et al., 1990b), in a significant subpopulation of the enzyme, heme a
becomes oxidized upon formation of PR,  while  CuA stays reduced (Oliveberg and Malmström,
1992). Also, PM and PR have  very  similar  kinetic  difference  spectra  with  peaks  at  607  nm
(Morgan et al., 1996; Sucheta et al., 1998), with the only significant difference being due to
heme a oxidation in the latter, indicating similar structures of the catalytic site with the O-O
bond already broken (Morgan et al., 2001) in both of these intermediates. However, due to
electron transfer from heme a in the latter case, it can be proposed that during formation of PR
the tyrosine radical is not formed, and the proton, required for O-O bond breakage, is picked up
from the cross-linked tyrosine with formation of the deprotonated tyrosinate. As with the
formation of PM, the appearance of PR is not coupled to proton uptake from the bulk solution
(Ädelroth et al., 1998b; Karpefors et al., 2000), but internal proton movement is very likely to
occur (Karpefors et al., 2000; Morgan et al., 2001; Paper IV). Formation of PR is a unique
transition in the catalytic cycle, because the electron transfer into the binuclear center during this
reaction is not coupled to external proton uptake, which occurs only in the next transition. Such a
feature of the ??PR transition could be due to preceding protonation of some internal sites upon
formation of COFR which would favor fast electron transfer.
Ferryl-oxo intermediate F. Intermediate F can be obtained in several ways: by the reversal of
electron transfer (Wikström, 1981) when high proton-motive force is applied to mitochondria (in
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fact, by increasing the strength of the proton-motive force, it is possible to reverse the oxygen
reaction even beyond F and reach PM); in the flow-flash reaction after PR with t ~ 120-140 ms in
bovine CcO (Hill & Greenwood, 1984; Oliveberg et al., 1989) or 50 ms  in  CcO  from
P.denitrificans (Ribacka et al., 2005); by electron injection into the stable PM state (Verkhovsky
et al., 1996b); or by incubation of oxidized CcO with excess amounts of H2O2 (Wrigglesworth,
1984; Vygodina & Konstantinov, 1988). Intermediate F can be easily detected by optical
absorbance spectroscopy as it has a characteristic peak at 580 nm in the F-minus-O difference
spectrum (e580-e630 ~  5.3  mM-1·cm-1).  From  the  structural  point  of  view  one  of  the  differences
between F and PR is an extra proton in the catalytic center in the former intermediate. This
proton is taken up from the N-side of the membrane via the D-pathway (Fig. 8), though the F
state can be formed even when the D-channel entrance is blocked by mutation (Smirnova et al.,
1999).  In this case, the required proton may be borrowed from one of the amino-acid residues
forming the channel - presumably GluI278(242). The final destination of the proton during the
P?F transition is uncertain but two possible candidates can be proposed: in one scenario this
proton reprotonates Tyr-O-, while in another it transforms the hydroxyl group on CuB to a water
molecule (Fig. 9). Proton uptake to the catalytic center during the P?F transition is also coupled
to CuA?  heme a electron re-equilibration (Oliveberg et al., 1989), where approximately 60% of
CuA becomes oxidized (Hill, 1991).
Fully-Oxidized High-Energy state, OH. The OH state is a final product in the classical flow-flash
reaction of the fully reduced CcO with dioxygen. It appears with a time constant of 1-2 ms (Hill
and Greenwood, 1984; Oliveberg et al., 1989; Hill, 1991) from F and requires delivery of both
an electron and a proton to the catalytic site. While the electron migrates from the CuA/heme a
couple, the proton is taken up via the D-pathway (Konstantinov et al.,  1997)  as  in  the PR?F
transition. Most likely, this proton goes to the oxygen atom at the heme a3 iron, resulting in two
possible configurations of the catalytic center: in one case (left branch in scheme, Fig. 9) both
heme a3 and CuB have hydroxide ligands, while in the other, these two metal centers share water
and hydroxide molecules. In the latter case, the hydroxide ion and the molecule of water form a
resonance structure with a preferable configuration in which the water molecule is bound to the
heme a3 iron and hydroxide to CuB. The fully-oxidized OH state is referred to as a “high-energy”
state implying that the energy released in the redox reactions of the oxidative part of the catalytic
cycle is conserved in this intermediate (Verkhovsky et al., 1999b), and will be used in the next
transitions of the cycle for proton pumping (Paper III&V). The OH state  is  not  stable  and  in
certain conditions, when the electron donors are exhausted, it relaxes into the low energy O state
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(incapable of pumping protons upon reduction) possibly by a protonation of a hydroxyl to water,
or tyrosinate to tyrosine. In spite of the energetic difference no spectral distinction between O
and OH intermediates has been found (Jancura et. al., 2006).
One-electron reduced EH. Discovery of the metastable high-energy OH state had led to the
conclusion that its reduction will result in formation of a one-electron reduced state, which will
be different from the relaxed E state created by the reduction of the resting CcO (Paper III&V).
Not much is yet known about the structure of this intermediate; however recent results indicate
that the CuB center receives an electron upon the OH?EH transition (CuB2+?CuB+)  with  a
“chemical” proton being delivered to the catalytic center (Paper V).
2.6 Proton Pumping
From the discovery of cytochromes by David Keilin in the 1920s (Keilin, 1925&1927) it took
more than 40 years of investigation (Slater, 2003 for historical review) to find that CcO
conserves energy by maintaining a DmH on a membrane, by virtue of the vectorial organization of
its  chemistry  (Chapter  2.1),  and  10  more  years  to  discover  that  for  maximal  efficiency  the
enzyme can perform active transport of protons from one side of the membrane dielectric to the
other (pumping). As was first shown by Wikström (1977) with rat-liver mitochondria and
confirmed later with bovine CcO reconstituted in phospholipids vesicles (Wikström & Saari,
1977; Krab & Wikström, 1978; Casey et al., 1979), reduction of each dioxygen to two molecules
of water is coupled to pumping of protons across the membrane.
2.6.1 Stoichiometry of Proton Translocation in the Catalytic Cycle
The first attempts to correlate proton pumping with certain transitions in the catalytic cycle were
done by a quasi equilibrium approach involving reversal of the oxygen reduction reaction. The
application of a high electrochemical proton gradient across the inner mitochondrial membrane,
with high Eh, and relatively high pH of the medium, creates specific conditions in which some
catalytic steps of dioxygen reduction can be reversed. Thus, addition of a high concentration of
ATP to well-coupled mitochondria in the presence of ferricyanide leads to formation of the P
and F states (Wikström, 1981; Wikström and Morgan, 1992). Analysis of the yields of the F and
P intermediates as a function of the applied driving force at different pH values (Wikström,
1989) led to the conclusion that the four electron transfer steps in the catalytic cycle are not equal
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with respect to proton pumping, and all four protons are pumped in two equal parts only during
the P?F and F?O transitions.
These conclusions were challenged by Michel (1998), who re-analyzed the original experiments
and proposed a new model. The stoichiometry of the proton pumping predicted by this model
was two protons in P to F, one in F to O, and one more proton in the reductive part of the cycle
presumably during the E to R transition.
Detailed analysis of membrane potential generation combined with parallel optical
measurements of the flow-flash reaction showed that both P?F and F?O transitions generate
approximately equal amounts of potential (Verkhovsky et al., 1997; Jasaitis et al., 1999).
However, despite having an extremely good signal/noise ratio for the electrometric signals, this
method does not directly give the number of transferred charges. One solution to this problem is
to use an internal standard for the calibration. Such independent calibration of potential
generation can be obtained, for example, from the electron backflow reaction (chapters 4.1&5.2),
which, at neutral pH, consists of a single electrogenic event – electron transfer from heme a to
CuA. But even in this case calibration is complicated by uncertainty about the dielectric distance
between these redox centers, i.e. how deep heme a is buried in the membrane and thus, the
distance traversed through the membrane by an electron moving from heme a to CuA (Jasaitis et
al., 1999). The X-ray crystallographic structure of the oxidase (Iwata et al., 1995; Tsukihara et
al., 1995) and experimental determination (Verkhovsky et al., 1999b; Paper II) of the dielectric
depth of heme a both gave the value 1/3 – implying that the pumping stoichiometry is one in both
the P?F and F?O transitions.
Direct measurements of both proton and charge translocations in CcO vesicles during partial
turnover of the enzyme (Verkhovsky et al., 1999b; Paper III) show that only two protons are
pumped in the oxidative part of the catalytic cycle: one during ??F, and another during ??O.
However the reaction is supplemented by two more pumped protons when the oxidation is
followed by immediate re-reduction. Since reduction of the fully-oxidized O state is not coupled
to proton pumping (Verkhovsky et al., 1999b; Ruitenberg et al., 2000; Verkhovsky et al., 2001b;
Paper III), a new “high-energy” fully-oxidized OH intermediate with energy conserved for proton
translocation was proposed.  Indeed, by electron injection experiments it was demonstrated that
one electron reduction of OH leads to formation of a new EH state and that this process is
coupled to translocation of one proton across the membrane (Paper III&V). Since the overall
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stoichiometry of proton translocation is four protons per dioxygen, reduction of the EH state
must also be coupled to a translocation of a proton (Paper III). The proton pumping during
reduction  of  the EH state  is  consistent  with  the  experiments  by  Ruitenberg et al. (2002), who
produced the EH state during the reduction of the F state by CO.
The recent results have been developed into a symmetrical scheme of the pumping events during
the catalytic cycle of CcO (Fig. 10). Under continuous turnover conditions CcO proceeds via
four relatively stable intermediates: PM, F, OH, and EH.  Single  electron  reduction  of  each  of
these four intermediates from cytochrome c leads to uptake of a “chemical” proton from the N-
side with simultaneous translocation of another proton across the membrane.
Figure 10.  The proton translocation during the catalytic cycle of cytochrome c oxidase. The
active states are shown in squares. The transitions between each of them are coupled to proton
pumping. The relaxed states are shown in circles; their reduction is not coupled to proton
pumping.
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2.6.2. Models of Proton Translocation
For many years, it was an almost universal assumption that proton pumping is coupled to the
reduction and oxidation of certain redox centers of CcO, and at different times each of the four
redox centers was considered to be a crucial element in the mechanism of proton translocation.
A model based on ligand exchange at the CuA site linked to its oxidoreduction was proposed by
the Chan group (Gelles et al., 1986). In this model reduction of CuA induces a change of the CuA
ligation state, which results in transfer of a proton from a tyrosine residue below CuA to one of
the  cysteine  ligands  of  CuA. Upon subsequent oxidation of CuA by the binuclear center, the
system returns to its original configuration with release of the translocated proton from the
cysteine and reprotonation of the tyrosine residues. However this model seems to be unfeasible
because structurally similar quinol oxidases are still able to pump protons even in the absence of
a CuA center.
Heme a was probably the most popular candidate to be the key cofactor for proton pumping. For
more than 20 years after discovery of proton pumping the idea of tight coupling between heme a
oxidoreduction to proton pumping was the basis for many models (Wikström et al., 1977;
Artzatbanov et al., 1978; Babcock and Callahan, 1983; Rich et al., 1998; Yoshikawa et al., 1998;
Michel, 1998; Papa et al., 1998). In general it was proposed that reduction of heme a is coupled
to uptake of a pumped proton from the N-side of the membrane. Subsequent electron transfer
from heme a to the binuclear center would be linked to uptake of another proton from the N-side
for water formation, and release of the preloaded proton towards the P-side of the membrane.
Rousseau et al. (1993) proposed a model where oxidoreduction of heme a3 is linked to a change
in its ligand configuration: in one redox state a histidine residue occupies the fifth coordination
site of the heme, while in another the histidine may be substituted by a tyrosine. Such exchange
at heme a3 would lead to proton translocation from the tyrosine to histidine and further to the P-
side of the membrane.
Several models have put oxidoreduction of CuB as a central element in the proton translocation
mechanism. Mitchell (1988) proposed that protonation of a hydroxyl ligand on the copper, by a
proton taken from the N-side of the membrane, resulting in a water molecule bound to CuB.  This
would be followed by re-orientation of the water molecule towards the P-side, after which the
proton is released due to CuB oxidation. Another model (Larsen et al., 1992) that posits CuB as a
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central element in the proton pump is derived from Chan’s CuA model of ligand exchange. A
“histidine cycle” model presented in 1994 (Morgan et al., 1994) specifies one of the conserved
histidine ligands of CuB as a pump element. According to this model, this histidine shuttles
between two conformations depending on the reduction level of CuB. In one conformation, the
histidine is deprotonated (imidazolate form, Im-) and bound to CuB, while in another form, it is
protonated (imidazolium, ImHH+)  and  rotated  away from CuB.  Arrival  of  a  chemical  proton  at
oxygen induces proton ejection from the imidazolium towards the P-side of the membrane, and
provides driving force for the reaction.
In contrast, recent models do not focus on any individual redox cofactor as the driving element
of proton translocation but rather the transfer of an electron from heme a to the binuclear center
(Siegbahn et al., 2003; Popovi? and Stuchebrukhov, 2004; Siletsky et al., 2004); or of a proton
from the conserved GluI278(242) to a proton pump site above the hemes via a chain of water
molecules (Wikström et al., 2003; Paper IV&V) which then triggers electron equilibration
between the hemes. In spite of the fact that these two types of models differ with respect to the
order of the electron and proton steps, and which one drives the reaction, these models are quite
similar. The initial electron (heme a to  the  binuclear  center)  and  proton  (from  GluI278 to the
pump site) transfers are followed by uptake of a chemical proton to the active site, which leads to
release of the pumped proton from the protein on the P-side.
A model that is completely different from the electrostatic models just described has recently
been proposed by the Brzezinski group. Based on the kinetics of proton uptake and release on
both aqueous sides of the membrane, it is suggested that proton pumping is not coupled to
internal electron transfer, but rather occurs as a result of energy conservation in the protein
structure in response to transfer of a chemical proton to the active site (Brzezinski and Larsson,
2003; Faxen et al., 2005).
So, the long history of CcO studies has produced a large number of models to explain the proton
pump mechanism; many of these models have already been disproved, but we should admit that
there is still no single widely accepted theory present.
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3. AIMS OF THE PRESENT STUDY
The first crystallographic structures of CcO with atomic resolution were obtained more than 10
years ago; however at the time when this work was started there was still no clear information
about the molecular mechanism of the proton pump in CcO. Results obtained by different groups
were sometimes contradictory making understanding of CcO functioning, which is extremely
complicated itself, even more complex. The main task of this work was to carry out extensive
studies of pumping and non-pumping terminal oxidases by a variety of different complementary
techniques (absorbance spectroscopy, potentiometric electrometry, and proton pumping
measurements) examining full and partial steps of the catalytic cycle. More specifically, the main
aims were:
· To explore and compare the dioxygen binding properties of the terminal oxidases from
the distinct heme-copper and bd-type families.
· To study the electron reversal reaction after CO photolysis from the mixed-valence CO-
bound CcO under different pH conditions, and to use this reaction to estimate the relative
dielectric depth of the binuclear center within the membrane.
· To perform a detailed analysis of the oxidative and reductive parts of the catalytic cycle
to clarify the steps in the reaction that are coupled to proton translocation, and estimate
the number of protons translocated at each of these steps.
· To study the individual steps of proton translocation to locate the reaction that drives the
proton pumping mechanism.
· To explore one of the single proton translocation steps in CcO in real time to define
thermodynamic and kinetic properties of the proton pump, and describe the proton pump
mechanism at the atomic level.
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4. METHODOLOGY
4.1. Methodological Approaches
The typical rate of oxygen reduction by CcO under steady-state conditions is approximately 100-
200 enzyme revolutions per second. This means that a single turnover of the enzyme is
extremely fast and occurs in the millisecond time domain. At the same time, each turnover has a
number of distinct intermediates which are formed in times ranging from a few microseconds to
several milliseconds after the beginning of the reaction. Thus, because of a large number of
catalytic intermediates, complicated by a large hierarchy of transition rate constants between
them, it is impossible to study the mechanism of CcO functioning by means of conventional
steady-state techniques. The main problem in the steady-state approach is that under such
conditions only the longest lived intermediate is populated, leaving all other intermediates
completely invisible. The transient kinetics approach makes it possible to overcome these
difficulties, but requires a certain number of conditions which have to be fulfilled.
· First, the measuring system must allow time resolution faster than the fastest reaction
step under investigation. This is actually the least difficult matter nowadays due to
developments in the field of modern electronics (e.g. development of the CCD (Charge
Coupled Device, an image sensor consisting of a large number of capacitors for light
registration), fast Analog-to-Digital converters, powerful computers for real-time
processing etc.).
· Second, the sample solution consists of a very large number of individual protein
molecules that function independently, and it is very important to set all of them into the
same state before initiation of the reaction.
· Third,  addition  of  substrates  to  the  enzyme has  to  be  carried  out  faster  than  the  fastest
transition under investigation. This is a real challenge because the fastest mixing time of
a conventional stopped-flow apparatus is in the range of milliseconds, which is much
slower than most of the intermediate transitions in the catalytic cycle. A possible solution
to this problem is to start the reaction by instant enzyme activation, for example by a
laser flash.
The catalytic reaction of CcO consists of oxygen reduction chemistry together with proton and
electron transfers. In general, electron transfer can occur in two opposite directions: to and from
the binuclear center. In the first case, the movement of electrons coincides with the normal
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physiological direction of electron transfer, while the other case is an artificial experimental
model used for detailed studies of electron transfer reactions (backflow reaction).
Two main approaches have been introduced for measurements of the catalytic reactions in CcO
in  real  time.  One  of  them  -  the flow-flash method (Gibson and Greenwood, 1963) - is a
combination of the conventional stopped-flow technique with laser-induced initiation of the
reaction. In this method, instead of initiating the reaction by the actual mixing of the fully-
reduced CcO with dioxygen, the enzyme is first allowed to react with carbon-monoxide, which
binds to the reduced heme a3 at the oxygen binding site; after that the CO-bound oxidase is
mixed in a stopped-flow apparatus with an oxygen-containing buffer. Under these conditions, the
reaction of dioxygen with the CO-bound oxidase is limited by the CO-dissociation rate (ca. 0.02
s-1 (Gibson and Greenwood, 1963&1964)5. However the Fe–CO bond is photolabile and before
spontaneous dissociation can take place, the entire population can be instantly photolysed by a
laser flash. The laser flash photolyzes CO from heme a3 allowing dioxygen to bind and begin the
reaction. The subsequent transitions can be monitored by a number of different time-resolved
detection techniques such as optical absorption spectroscopy (Gibson and Greenwood, 1963; Hill
and Greenwood, 1984; Orii, 1988; Oliveberg et al., 1989; Hill, 1991&1994; Blackmore et al.,
1991; Verkhovsky et al., 1994&1996a; Sucheta et al., 1998), potentiometric electrometry
(Verkhovsky et al., 1997; Jasaitis et al., 1999; Verkhovsky et al., 1999b), resonance Raman
(Varotsis et al., 1989; Han et al., 1990a; Ogura et al., 1990; Varotsis and Babcock, 1990;
Varotsis et al., 1993) etc.  The  flow-flash  method is  very  useful;  however  its  scope  is  restricted
and it is usually applied to studying the oxidative part of the catalytic cycle only. In addition, the
beginning of the reaction is complicated by the phase of CO release, which takes the same route
via CuB (Alben et al., 1981) as subsequent dioxygen binding (Verkhovsky et al., 1994).
Fortunately, CO dissociation from the binuclear center seems to be much faster (Woodruff et al.,
1991) than the subsequent step of oxygen binding, and should not affect it.
The second approach is the initiation of the reaction by the injection of a single electron into the
enzyme. The most successful implementation to date has been the use of photo-activated
ruthenium derivatives (Mayo et al., 1986; Nilsson, 1992; Zaslavsky et al., 1993; Geren et al.,
1995; Zaslavsky et al., 1998; Ruitenberg et al., 2000; Verkhovsky et al., 2001b; Siletsky et al.,
5 The rate of CO dissociation strongly depends on the intensity of the measuring light and under particular
experimental conditions it can be much faster than the cited value.
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2004; Papers III&V) such as tris(2,2’-bipyridyl) ruthenium (RubiPy) for the reaction initiation in
CcO. Under low ionic strength conditions RubiPy binds electrostatically to the oxidase at the
cytochrome c binding pocket. A laser flash promotes the molecule of RubiPy to an excited state
with an Em of about -1.5 V, which can then donate an electron to CuA in less than 0.5 ms. The
injected electron is further redistributed among all redox cofactors according to their midpoint
potentials. The reverse reaction of enzyme reoxidation by the oxidized RubiPy is prevented by
addition of a sacrificial electron donor such as, for example, aniline or EDTA. Electron injection
is a very powerful and useful technique, albeit with certain limitations: the main one is the
relatively small quantum yield, which is typically less than 10%.
An alternative way to study electron transfer in CcO is investigation of the electron backflow
reaction and processes coupled to it by the perturbed equilibrium method. In this method, CO
binding is used to maintain the apparent midpoint potentials of heme a3 and  CuB at high level
prior to the flash.  The bound molecule of CO can then be dissociated by a flash of light causing
the midpoint potentials of heme a3 and CuB to drop, and allowing electron redistribution among
all redox centers according to the new redox equilibrium (see Section 5.2).
4.2. Time-resolved Potential Electrometry
The functioning of CcO is directly linked to the translocation of both electrons and protons
across the membrane. Whereas the transfer of electrons can be relatively easily followed by
various spectroscopic methods, the time-resolved transfer of protons can conveniently be
measured by potential electrometry. Potential electrometry is a technique of direct measurement
of electric charge translocation by membrane proteins. It was originally developed for the study
of bacterial reaction centers and bacteriorhodopsin (Drachev et al., 1974&1979), but later also
applied to CcO (Zaslavsky et al., 1993). In recent years this technique has advanced extensively
allowing detection of DY generated not only in the light-induced reactions, but also after
addition of other substrates such as O2, or NO (Verkhovsky et al., 1997; Hendriks et al., 2002).
The idea of the electrometric technique is that, firstly, the molecules of CcO are incorporated
into phospholipid vesicles by gradual removal of detergent from the protein/lipid mixture
(Hinkle et al., 1979; Rigaud et al., 1995). Then the vesicles with CcO are fused to a planar lipid
measuring membrane through neutralization of the membrane surface negative charges by Ca2+
or Mg2+ ions (Fig. 11). The measuring membrane must be very thin in order to possess a high
electric capacitance to allow the recording of fast charge translocation. During the enzymatic
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reaction, CcO creates a DY across the vesicle membrane which is then proportionally divided
with the measuring membrane and thus can be detected by Ag/AgCl electrodes situated on on the
two sides of the measuring membrane. Typically, the measuring membrane has a resistance of
about 1-5 GOhm, and the measured DY decays with a time constant of several seconds, which is
slower than the typical rates of DY generation due to the enzymatic processes.
This method is extremely sensitive,
allowing detection of charge translocation
of  less  than  1  Å  across  the  membrane
dielectric in the direction perpendicular to
the membrane plane. At the same time it
has certain limitations natural for any
vesicle-related technique, for instance the
enzyme molecules may not all be oriented
in the same direction, decreasing the
amplitude  of  the  signal,  or  the  substrate
binding sites may be unreachable if they
are located on the inner side of the vesicle
membrane.
Figure 11.   Scheme  of  the  electrometric  setup.
CcO is reconstituted into phospholipid vesicles
that are fused to the phospholipid measuring
membrane. The potential measured between
Ag/AgCl electrodes is proportional to the potential
generated by the enzyme. Cm,  Cp,  Cc are  the
capacitances of the measuring membrane, the
liposomal membrane, and their contact region
respectively. Rm,  Rp,  Rc are the corresponding
resistances. Ri is  internal  resistance  and  Eg is the
electromotive force of the molecular generator.
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5. RESULTS AND DISCUSSION
5.1 Oxygen Binding Properties of Terminal Oxidases
5.1.1 Determination of the Oxygen Binding Constant
In contrast to mitochondria, bacteria are usually characterized by a highly branched composition
of  the  respiratory  chain  where  up  to  at  least  three  different  terminal  oxidases  are  available  for
expression (Anraku and Gennis, 1987; Garcia-Horsman et al., 1994). One of the main functions
of the branched organization of the respiratory chain is to adapt bacteria to a variety of
environmental growth conditions. Indeed, unlike the mitochondria that can benefit from the
stable  conditions  of  the  eukaryotic  cell,  bacteria  are  often  exposed  to  a  constantly  variable
environment and deprived of such stability. Since dioxygen is one of the main substrates
essential for survival of aerobic organisms, nature developed several types of terminal oxidases
that function under different oxygen conditions. Under normal oxygen concentration terminal
oxidases are presented by a proton-pumping heme-copper type of oxidases, while under low
oxygen tension the most pronounced is expression of non-pumping (Miller and Gennis, 1985;
Puustinen et al., 1991) cytochrome bd. Thus, it is interesting to compare the oxygen binding
properties  of  these  oxidases.  But,  if  for  CcO both  oxygen dissociation  constant  (Kd = 280-320
mM (Chance et al., 1975; Verkhovsky et al., 1994)) and Michaelis constant - the concentration
yielding half-maximal steady-state turnover (Km = 0.95-1 mM (Petersen et al., 1976; Verkhovsky
et al., 1996c)) are well defined, the same characteristics measured for cytochrome bd are less
certain. There is only one reported value of Kd = 25 nM for bd-oxidase (Hill et al., 1994), which
was however obtained indirectly using results from different experiments - the forward rate
constant (k1) from the oxygen reaction, and the reverse rate constant (k-1) from a ligand-exchange
(O2/CO) experiment without presenting real data for the latter case. Because of that the high
affinity of cytochrome bd to  oxygen  was  always  considered  to  be  based  on Km values. But on
one hand, the published Km values vary extensively from 3 nM to 2mM depending on the
concentration and nature of the primary substrate, experimental techniques, and other factors
(Rice and Hempfling, 1978; Kita et al., 1984; Kolonay et al., 1994; Jünemann et al., 1995;
D’mello et al.,  1996).  And on  the  other,  the  use  of Km as  a  measure  of  the  enzyme affinity  to
oxygen (i.e.  Kd = Km)  may often  be  incorrect,  except  in  the  simplest  case  of  a  single  substrate
reaction when k2 is very small, otherwise the k2/k1 ratio should be added to Kd to obtain Km:
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(3).
The difference between Km and Kd can be emphasized by comparing these values for CcO where
they differ more than 100-fold (Verkhovsky et al., 1996c).
In contrast to heme-copper oxidases, cytochrome bd can bind oxygen even in the one-electron
reduced state, forming a stable oxygenated complex ( 2
23
595
3
558 Odbb -
+++ ) characterized by an
absorbance spectrum with a maximum at 650 nm (I, Fig. 1A). Under anaerobic conditions it is
possible to remove all bound oxygen from cytochrome bd, and later regenerate the oxygenated
form by successive addition of aliquots of oxygen to the sample. The regeneration of the
oxygenated form is seen in the difference optical spectrum as an increase at 648 nm and a
decrease at 626 nm, due to a shift of the heme d a band maximum (I, Fig. 1B). The Kd value for
bd-oxidase can be defined by plotting and fitting of the fraction of oxygenated form (measured
as the absorbance difference between 648 and 626 nm) as a function of O2 concentration (I, Fig.
2). The fit to the experimental data was based on a simple model of reversible oxygen binding:
and yielded Kd ~ 280 nM. Thus the oxygen affinity of bd-oxidase is indeed extremely high; it is
about 3-fold higher than that of sperm whale myoglobin (~880 nM, Draghi et al., 2002), and 3
orders of magnitude higher than that of CcO.
Taking the values for Kd and the bimolecular rate constant for the interaction of oxygen with the
enzyme, it is possible to estimate and compare the population of the oxygenated complex at a
typical oxygen concentration in tissues (3 mM, Gnaiger, 2003) for both terminal oxidases, as
[ ]21 Okkon ´=  and doff Kkk ´= 1 .
Taking k1 as 1.38×108 M-1s-1 for CcO (Verkhovsky et al., 1994) results in kon = 414 s-1 (t ~ 2.4
ms), and koff = 3.9×104 s-1 (t ~ 25 ms), which indicates very weak binding of oxygen. This raises a
question; how is CcO ever able to work with such low affinity to oxygen, when the population of
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oxygenated form is only about 1%? A possible explanation may be in the rate of transformation
of compound A into the “peroxy” state (t = 30-40 ms (Oliveberg et al., 1989; Verkhovsky et al.,
1994)), which is approximately similar to the koff value. This means that CcO functions as a
kinetically effective trap for oxygen (Chance et al., 1975; Verkhovsky et al., 1996c), where the
molecule of bound dioxygen is rapidly reduced, before it can dissociate. In contrast, cytochrome
bd tends to populate the oxygenated complex, as can be estimated from the obtained kon = 6×103
s-1 (t ~ 170 ms) and koff = 560 s-1 (t ~ 2 ms) rates, based on k1 = 2×109 M-1s-1 (Hill et al., 1994).
Since cytochrome bd is a non-pumping oxidase it does not spend energy for proton translocation
across the membrane. Also it accepts electrons, not from cytochrome c, but from ubiquinol,
which is about 150 mV more negative (Em ~ 100 mV). Thus, this significant excess of redox
energy drop from ubiquinol/quinone to the oxygen/water couple can be invested solely into tight
binding of oxygen. After isolation, cytochrome bd in the “as prepared” state already exists in the
oxygen bound form (Lorence and Gennis, 1989) and the removal of oxygen is not an easy task.
Only exposing the enzyme to a medium with an oxygen concentration lower than Kd, or the use
of strong light under microaerobic conditions (see Section 5.1.2), can do the job.
5.1.2 Photolability of the Heme d-O2 Bond in Cytochrome bd
Despite the fact that oxygen binding to the “as isolated” form of cytochrome bd is reversible,
attempts to photolyse the heme d-O2 bond in the mixed-valence enzyme have not been
successful (Borisov et al., 2002). It has been concluded that, in contrast to myoglobin and some
other synthetic oxy-hemes (Ye et al., 2002; Fry et al., 2004), the quantum yield for
photodissociation of the heme d-O2 bond  is  effectively  zero.  In  order  to  check  this  feature  of
cytochrome bd, we investigated the oxygenated form of the enzyme under strong continuous
illumination. Because O2 binding to cytochrome bd is extremely tight, it is feasible to study
photodissociation under lower O2 concentration. Under microaerobic conditions ([O2]~800nM)
the illumination of the oxygenated cytochrome bd induced a decrease of absorbance at 648 nm
and increase at 626 nm (I,  Fig.  3A).  The  obtained  difference  spectrum of  optical  changes  was
virtually identical to the inverted spectrum of oxygen binding to heme d (I, Fig. 3B), which
indicates that the heme d-O2 bond is actually photolabile.
It seems that the difference between our present and previously reported results is most likely
due to different oxygen concentrations in the sample: while Borisov et al. (2002) tried to
photolyse heme d-O2 bond under high oxygen tension, we conducted the measurements under
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microaerobiosis. It is possible that, in addition to the high-affinity oxygen binding site at heme d,
there is also a low-affinity binding site within the protein, somewhere in a possible oxygen-
conducting channel. We propose that under microaerobiosis this putative low-affinity site is
empty allowing oxygen photodissociation away from heme d, whereas at high oxygen tension,
this site will be occupied, locking the photoexcited oxygen at heme d.  From our  data  it  is  not
possible  to  make  a  specific  assignment  of  the  low-affinity  site,  but  we  can  exclude  heme b595
since in our measurement this heme is oxidized and thus incapable of oxygen binding.
5.2 Electron Backflow Reaction
The coupling between internal electron and proton transfers in CcO can be studied not only in
the forward reaction of oxygen reduction to water, but also in a simpler experimental model -
electron backflow. Under anaerobic conditions a molecule of CO binds to reduced heme a3 in
place of oxygen and significantly increases the midpoint potential of heme a3 and CuB, trapping
electrons at the binuclear center (Fig. 12). However, the heme a3-CO bond is photolabile and can
be broken by a laser flash. Upon the flash, in several hundreds of femtoseconds, CO leaves heme
a3 and  transiently  binds  to  CuB (Woodruff et al., 1991). After CO dissociation the midpoint
potential of heme a3 returns to its original value, and the electron equilibrates among the redox
centers (Boelens and Wever, 1979; Morgan et al., 1989; Oliveberg and Malmström, 1991;
Verkhovsky et al., 1992; Ädelroth et al, 1995; Jasaitis et al., 1999) approaching a distribution
that depends on their midpoint potentials. Fast electron equilibration between heme a3 and heme
a takes place on the nanosecond time scale (Verkhovsky et al., 2001a; Pilet et al., 2004),
followed by a slower 2-3 ms process connected with a protein relaxation that takes place upon
CO release from CuB. The next step happens in 30-50 ms and includes further electron
equilibration among the hemes and CuA. At high pH, electron backflow is also supplemented by
a millisecond phase (t ~ 2 ms, pH 9) caused by additional electron equilibration among the redox
Figure 12. The  scheme  of  the  electron  backflow  reaction  from  the  mixed-valence  CcO.  Each
box represents one of the redox centers,  and can be completely or partially filled (reduced),  or
emptied (oxidized).
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centers in response to proton release from the binuclear center. It has been proposed that this
proton originates from a water molecule and is released to the bulk solution via the K-pathway
(Hallén et al., 1994; Brändén et al., 2003). This proton movement should create an electric
potential (DY) that can be detected and used to estimate the relative dielectric depth of the
binuclear center within the membrane (d).
Typical traces of DY generation in the backflow reaction in the COMV state at different pH
values are shown in II, Figure 4. Only a very small (~0.25mV) amplitude of DY generation was
detected in CcO in P. denitrificans at neutral pH. However upon increasing the pH, the
amplitude of DY generation increased, reaching 8.2 mV at pH 10. In the pH range 7-8.5, the time
constant of charge translocation was about 50-60 ms, but in alkaline conditions it slowed to ~200
ms at pH 10.5 (II,  Fig.  5),  however  without  any  detectable  component  in  the  millisecond time
domain. Thus there is a clear difference between the optical and electrometrical results in
alkaline  conditions.  To  clarify  the  source  of  this  difference  a  definitive  assignment  of  the
electrometric signal was performed by means of parallel optical measurements and the use of
proton channel blocking mutants.
On one hand the rate of DY generation is very close to the rate of electron transfer between heme
a and  the  CuA center, and it is possible that in alkaline conditions the extent of the electron
transfer to CuA in the two-electron reduced enzyme is much higher than at neutral pH. However,
the direct comparison of optical traces of CuA oxidoreduction in the electron backflow reaction
in alkaline conditions from COMV, COFR, and 3e- reduced enzyme clearly showed that there
was no CuA reduction in the COMV case (II, Fig. 6, reduction of CuA corresponds to a decrease
in  absorbance  at  820  nm).  All  other  redox centers  in  CcO are  located  at  about  the  same depth
within the membrane dielectric and electron equilibration among them cannot produce any DY.
Thus, the 50-200 ms phase of DY generation should derive only from the proton transfer towards
the N-side of the membrane. Indeed DY generation measurements with D- and K- channel
blocking mutants supported this assignment (II, Fig. 7). While the amplitude of DY generation
for the D124N enzyme was almost unaffected by the mutation (it had approximately the same
amplitude and the same rate as for the wild type oxidase), blockage of the K-channel (K354M
mutant) resulted in complete disappearance of the signal in the mixed-valence enzyme. This
agrees with previous results from time-resolved optical measurements on the analogous K-
channel mutant in Rhodobacter sphaeroides CcO, where the millisecond electron-transfer phase
was also not detected (Ädelroth et al., 1998a). Taken together, the obtained results suggest that
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the 50-200 ms phase of DY generation is due to proton transfer through the K-pathway, and are
consistent with the fact that uptake of the first and second protons during reduction of CcO from
the O state happens also via the K-pathway (Ädelroth et al., 1998a; Wikström et al., 2000). If so,
what can explain the apparent contradiction that when proton release, coupled to electron re-
equilibration, is measured by the electrometric method, a time constant of about 150 ms is found,
whereas the proton ejection from the enzyme, as measured using pH-sensitive dye (Brändén et
al., 2003), and electron equilibration itself is observed only on millisecond time scale?  It seems
that the difference in the rates is due to the fact that the enzyme is not in the same physical
environment in typical optical and electrometrical measurements. In one case the enzyme is
exposed to a detergent containing environment, while in the other it is reconstituted into
phospholipid vesicles. This idea is supported by optical measurement of the backflow reaction
with the reconstituted CcO, where the rate of the second electron transfer phase was significantly
faster  than  in  detergent  solution:  about  6.7  ×  104 s-1 (t = 150 ms)  at  pH  9.5  (II, Fig. 8). Two
feasible explanations of this increase may be proposed: either incorporation of the enzyme into
the vesicles significantly changes the conductivity of the K-channel, or the large number of
negative charges on the membrane surface may serve as a proton acceptor pool increasing the
proton release rate.
Taking the maximal amplitude of DY in the backflow reaction from the fit to the experimental
data as 9.84 mV (II, Fig. 4B), it is possible to estimate the relative dielectric depth of the hemes
within the membrane. But that requires knowledge of the total extent of electron transfer
between the binuclear center and the heme a/CuA couple after CO dissociation from COMV. The
amplitude of electron transfer in this process can be obtained from the CO recombination rates in
the COMV and COFR enzymes (II, Fig. 1). In both cases the kinetics of CO recombination were
monophasic at any pH from 7 to 11. In the COFR enzyme the observed rate was about 44 s-1, and
pH independent, while in the mixed-valence enzyme the rate decreased from 20 s-1 at pH 7 to 1 s-
1 at  pH  11,  which  is  similar  to  the  CO  recombination  rates  measured  on R. sphaeroides CcO
(Sigurdson et al., 2002). The pH independence in the COFR case indicates that the CO
recombination as such does not involve protonation events. In COMV however, the decrease in
the rate with pH can be explained by a decrease of the occupancy of the fully-reduced binuclear
site after CO photolysis, due to electron transfer to heme a (Morgan et al., 1993). Therefore, the
rate of CO recombination in the mixed-valence enzyme can be described by the equation:
)]([)( 30 pHakpHk
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where krec is  the apparent rate constant of CO recombination at  a particular pH value; k0 is the
CO recombination rate constant in fully-reduced enzyme; and [a3red]  is  the  fraction  of  fully-
reduced binuclear center. [a3red] can be estimated from the measured rates of CO recombination
in COMV at different pH values. Amplitudes of [a3red] were fitted with a Henderson-Hasselbalch
one-proton titration curve (II, Fig. 1C) giving a pKa value of 8.66 (Hill coefficient 0.6). From the
fit the maximal extent of the fully-reduced binuclear center after the fast phase can be calculated
to be 50.5%. A Hill coefficient less than unity indicates negative cooperativity with several other
titratable groups. Since there is only a decrease in the Hill coefficient without any splitting of the
titration curve, we can conclude that these titratable groups are located, not near, but rather quite
far away from the titratable water molecule in the binuclear center.
The amplitude of DY generation in the reaction of the fully-reduced CcO with dioxygen was 105
mV which corresponds to the translocation of 2)1(2 ´-++ dd charges - two protons across the
membrane (pumping); one electron via d-span  of  the  membrane  due  to  electron  transfer  from
CuA to heme a, and two more protons through (1-d) span of the membrane for water formation.
At the same time, the translocation of 0.505 protons via (1-d) in the backflow reaction from
COMV in alkaline conditions generates 9.84 mV of potential. When these numbers are taken
together they can be used to estimate the relative dielectric depth of the binuclear center within
the membrane (d):
32.0,
505.0)1(
84.9
2)1(2
105
=Þ
´-
=
´-++
d
d
mV
dd
mV
.
The value of d = 0.32 is in a good agreement with the previous estimate based on electron
equilibration between heme a and  CuA in the 3-electron reduced enzyme (Verkhovsky et al.,
1999b), and with the crystallographic structure (Iwata et al., 1995).
5.3 Stoichiometry of Proton Translocation
The results from direct measurements of both proton and charge translocation processes in CcO
reconstituted into phospholipid vesicles suggested (Verkhovsky et al., 1999b) that only two out
of four protons are pumped during the oxidative phase of the catalytic cycle (one in P?F, and
one in F?O). However, when the oxidative phase is followed by immediate re-reduction, this
results in additional pumping of two more protons. In contrast, reduction of oxidized, as isolated
enzyme (state O) is not coupled to proton pumping (Verkhovsky et al., 1999b; Ruitenberg et al.,
2000; Verkhovsky et al., 2001b) in agreement with the low midpoint potentials (Em) of heme a3
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and CuB from anaerobic redox titrations (Dutton and Wilson, 1974). It was proposed
(Verkhovsky et al., 1999b) that the intermediates formed in the reductive phase starting from the
oxidized enzyme, as isolated, and from the oxidized enzyme in the continuous turnover are
different, implying existence of two alternative catalytic pathways that differ in efficiency of
proton pumping.
To establish the stoichiometry of proton pumping in the re-reductive phase of the catalytic cycle
(OH?EH?R) we conducted direct measurements of proton translocation in CcO vesicles. These
experiments showed that only two protons are pumped when the enzyme, fully reduced by a
stoichiometric amounts of donor, is oxidized by dioxygen (III, Fig. 2), and nicely fits a
simulation curve in which it is assumed that one proton is pumped during the each P?F and
F?O transition step. At the same time, when two additional electron equivalents were present
after the oxidation (in the form of reduced cytochrome c) this led to translocation of two more
protons by CcO. Even though these results provide further support for suggestion by Verkhovsky
and coworkers (1999b), they are not precise enough to make a distinction between two possible
models for proton pumping during enzyme re-reduction. In the first model (III, Fig.2, upper
curve) the OH?EH transition  is  associated  with  pumping  of  two  protons,  while EH?R is
completely non-pumping; in the second, both of these steps are associated with pumping of one
proton (III, Fig.2, lower curve).
The re-reduction of the OH state can also be studied by laser-induced electron injection from the
photosensitive dye RubiPy (tris(2,2’-bispyridyl)ruthenium [II]) and measured by time-resolved
potential electrometry. In these experiments CcO was incorporated into phospholipid vesicles
and  was  initially  fully  reduced  in  the  presence  of  CO  to  form  a  stable  heme a3-CO complex.
Addition of dioxygen into the anaerobic sample was followed by a laser flash to photolyse CO
which allows the binding of O2,  followed by the oxidation of the enzyme (III, Fig. 3AB, blue
trace). The first flash was then followed by a series of flashes to photoinject electrons from
RubiPy into the OH state  (III,  Fig.  3AB,  red  traces)  with  a  quantum  yield  of  about  20%  (as
measured using K354M mutant enzyme, similar to Verkhovsky et al. (2001b)). Upon excitation,
during each flash, the CuA site becomes reduced in a 20% population of the enzyme, with a time
constant of less than 0.5 ms. After that, the injected electron first equilibrates between CuA and
heme a with a time constant of ~10 ms. This is then followed by a slower reaction phases that
includes  electron  delivery  to  the  catalytic  site  and  several  phases  of  proton  transfer.  Since
electron equilibration between CuA and heme a, and transfer of protons occur across the
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membrane they will be involved into DY generation. The amplitude of DY generation during
each flash remained almost constant for more than 16 flashes with wild-type CcO, while the
mutation of the conserved LysI354 in the K-pathway to methionine (K354M) resulted in strong
inhibition of DY generation  (III, Fig. 3B, red traces). This effect was, however, expected
because it is well known that the reduction process in the K354M variant is strongly inhibited
(Vygodina et al., 1998; Ädelroth et al., 1998a; Wikström et al., 2000).
The kinetics of DY generation from a single flash into the OH state of wild-type CcO comprised
four kinetically distinguishable phases (III, Fig. 3C; V, Fig. 2B). First, a ~10 ms event (relative
amplitude 12%) is due to electron equilibration between CuA and heme a, where approximately
70% of the electron population has moved to heme a (Paper V). The fast phase was followed by
three phases of proton translocation with time constants of 150 ms, 800 ms, and 2.6 ms and
relative amplitudes 42%, 30%, and 16% respectively.
The fast (10 ms) electron transfer phase can serve as an internal calibration of the proton transfer
steps and makes it possible to estimate the overall charge translocation during the slower
processes.
64.1chargesofnumber
chargesofnumber
16%30%42%
7.0
%12
=Þ
++
=
´d
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dielectric depth of the hemes in the membrane (section 5.2). Hence, the data suggest that the
electron transfer to the binuclear site at the OH state is accompanied by uptake of a substrate
proton (across 1-d, ~0.64 charges), and pumping of another proton across the membrane.
We conclude that anaerobic reduction of the OH state is coupled to translocation of two protons
across the membrane: one of these protons is translocated during the OH to EH transition, which
defines the pumping stoichiometry for the next EH to R step also as one proton. This conclusion
is supported by the virtual independence of the amplitudes of DY generation during more than
16 successive flashes. Each flash injects a single electron into a subpopulation of the enzyme,
and as the sequence of flashes proceeds, and electrons accumulate in the enzyme, a considerable
amount  of  the  enzyme  will  then  proceed  through  the PM to F, and F to OH steps due to the
aerobic conditions. Comparison of the amplitude of DY generation during the initial O2-reaction
phase (first laser shot) with the amplitude generated during subsequent electron photoinjection
events provides an additional control of the signal calibration. The amplitude of DY generation
during the electron injection events was approximately 10 times smaller than during the
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oxidation phase (III, Fig.3A). The quantum yield of electron injection was ~20%; when the
signal  was  extrapolated  to  100%  it  became  about  two  times  smaller  than  the  amplitude  in  the
oxidative phase (~34 mV vs. 60 mV), which is in a good agreement with the number of charges
transferred in each of these reactions: 2 charges vs. 3.68 charges.
Based on the results presented here a general picture of the proton translocation steps can be
drawn. The oxidative phase of the catalytic cycle is coupled to pumping of two protons: one in P
to F,  and  one  in  the F to OH transition. In continuous turnover, oxidation is followed by
immediate re-reduction of CcO from cytochrome c, and in this case each transition in the
reductive part of the catalytic cycle is also coupled to proton pumping of a single proton during
each OH to EH and EH to R (Fig. 10).
Figure 13. Proton pumping on oxidation and
re-reduction after a pulse of oxygen saturated
water. A. measurements of pH changes. Blue
line, experimental curve; green line, after
subtraction of protons originating from
ascorbate oxidation; red line, the fit of the re-
reduction part of the reaction with parameters:
t1 ~ 42 s (amplitude, -0.0030), and t2 ~ 150 s
(amplitude, 0.0076). B. Optical changes at
445-470 nm. Conditions: CcO in liposomes;
KCl, 100mM; valinomycin, 1mM; sodium
ascorbate, 1mM; monensin, 3nM.
The lifetime of the OH state is unknown due to
experimental  difficulties.  However  we  can  try
to estimate the lifetime of this intermediate
based on results from the proton pumping
measurements (Fig. 13). For these
measurements, CcO reconstituted into vesicles
was made anaerobic and fully reduced using a
small amount of ascorbate. After that, the
oxygen reaction was initiated by a
stoichiometric pulse of oxygen and the
resulting reaction was followed by optical
spectroscopy  as  well  as  with  simultaneous
measurement of pH changes in the medium.
The slow rate of the re-reduction process under
these experimental conditions makes it
possible to separate proton release during the
oxidative and the subsequent re-reductive
phases. The pH changes which follow the
pulse  consist  of  two phases  (Fig.  13A,  dashed
trace): the fast phase is due to the proton
pumping during the oxidative part, and the
slow phase consists of events that take place
during re-reduction of the enzyme: the release
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of protons pumped in this phase, as well as protons released when ascorbate becomes oxidized.
Under  present  experimental  conditions,  about  0.5  H+/e- are released into the medium due to
oxidation of ascorbate. The rate of ascorbate oxidation (and therefore the rate of proton release
from ascorbate) is determined by the rate of the enzyme re-reduction (Fig 13B). Using these
data, it is possible to determine the pH changes that result from the oxygen pulse, excluding the
protons from ascorbate (Fig. 13A, black solid line). According to a calibration using injections of
anaerobic acid, about 1.5-1.6 protons per O2 were pumped in the oxidative part of the cycle. The
pH changes during the re-reduction phase could be fitted by a 2 exponential function with the
following parameters: t1 ~ 42 s (amplitude, -0.0030), and t2 ~ 150 s (amplitude, 0.0076). The
amplitude of the first component reflects additional pumping, which is linked to the enzyme re-
reduction, of about 2.2 H+ per enzyme. Since this is the full amplitude of proton pumping
expected, it appears that little decay of the OH intermediate has taken place, and that the lifetime
of this state must be at least 30-40 seconds. The second component has the opposite sign, and
reflects the uptake of protons for the reduction of oxygen to water and is defined by the slow rate
of proton exchange between the vesicles’ interior and the external reaction medium.
5.4 Proton-linked Electron Transfer from Heme a to Heme a3 is the Driving
Reaction in the Mechanism of Proton Translocation by CcO
As discussed in the previous section, proton translocation occurs four times during the catalytic
cycle of CcO. Each of these transitions is associated with delivery of an electron to the catalytic
site, and is coupled to uptake of a substrate proton from the N-side of the membrane to form the
equivalent of water. Thus, it is very likely that the mechanism of proton translocation at each
step  is  essentially  the  same,  with  the  only  variation  in  the  final  destination  of  the  injected
electron.  But  in  order  to  proceed  further  in  understanding  the  actual  mechanism  of  the  proton
pump, it is important to establish a driving element or reaction that pushes the pump into the
right direction. One approach to this problem is to study the earliest part of the oxygen reaction
with fully-reduced CcO, because here it is possible to kinetically distinguish electron transfer
from heme a to the binuclear center (during A?PR) from the next step (PR?F) - when uptake of
both the substrate and the pumped protons take place from the aqueous N-side.
The combination of time-resolved optical spectroscopy with potential electrometry is a tool that
gives information about both redox changes of the metal centers and vectorial movement of
protons during transitions of the catalytic cycle. The DY generation in the reaction of the fully-
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reduced CcO with oxygen at neutral pH develops in two major kinetically distinguishable phases
(IV,  Fig.  2a)  that  were  previously  assigned  to  the PR?F and F?O transitions (Jasaitis et al.,
1999). In the first two phases, R?A and A?PR, Jasaitis et al. (1999) observed little or no
electrometric signal and concluded that there was essentially no charge transfer during these
transitions. Formation of compound A is indeed not linked to any charge movement, while the
next phase includes electron equilibration between heme a and the binuclear center. Even though
this electron equilibration is electrometrically silent itself, due to the location of donor and
acceptor at the same depth within the membrane, it is possible that this process is linked to some
internal proton movement. However the large amplitude of DY in the subsequent reaction step
might overwhelm possible signal of such charge translocation during A?PR, obscuring the
amplitude of the earlier phase in a multi-exponential fit. When we studied the oxygen reaction in
alkaline conditions, where the rates of both PR?F and F?O transitions are known to be
decelerated (Brändén et al., 2005), the rate of the slow DY generation step (F?O) was indeed
slowed down, but the rate of the preceding electrometric phase appeared to be accelerated with a
shortening of the initial lag phase (IV, Fig. 2ab). Furthermore, in alkaline conditions the fast
phase of DY generation overlapped in time with the kinetics of the earlier reaction step (A?PR)
as measured spectroscopically (IV, Fig. 2c). This indicates that DY is  already  beginning  to
develop during A?PR and  that  the  fast  phase  of DY generation actually consists of two
electrogenic phases that are differently affected by pH. The amplitude of DY generation during
A?PR is pH-independent, while during the following PR?F it is initially large but decreases
with pH.
Additional support for DY generation during A?PR was obtained from measurements on the
AspI124 to asparagine (D124N) mutant enzyme. In the D124N mutant the entrance of the D-
pathway is blocked by the mutation, which impairs proton pumping (Thomas et al., 1993a; Fetter
et al., 1995) and strongly inhibits proton transfer through the D-channel (Smirnova et al., 1999).
Because the amplitude of the major electrogenic phases during the PR?F and F?O transition
steps are decreased in D124N, it is possible to resolve the early transient during A?PR. The fast
phase of DY generation in D124N, measured at pH 7, coincided with the fast phase in the wild-
type enzyme at pH 10.5 indicating that the early phase of charge translocation during the A?PR
transition also occurs at neutral pH (IV, Fig. 2b).
The importance, for the proton pumping mechanism, of the electron transfer that takes place
during A?PR can be assessed by studying the oxygen reaction starting from the mixed-valence
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state of the enzyme, where only heme a3 and  CuB are reduced, and the electron transfer from
heme a does not take place. In this case the oxygen reaction is not coupled to any charge
translocation (Jasaitis et al.,  1999),  though  the  scission  of  the  O-O  bond  occurs  in  the  normal
way. This demonstrates that the early charge translocation during A?PR completely depends on
the electron transfer from heme a to the binuclear center.
From  the  amplitude  of DY generation during A?PR (~8% of DY generation during oxidative
part of the catalytic cycle) it is possible to estimate the relative distance of the charge transfer in
this step. Since during R?O about 3.68 charges are transferred across the membrane
(Verkhovsky et al., 1999b), the A?PR transition will be coupled to transfer of one electrical
charge across ~27% of the membrane dielectric. From the fact that the electron equilibration
from heme a and the binuclear center is electrometrically silent, we can assign this charge
translocation phase to internal proton movement towards the P-side of the membrane. The
conserved residue GluI278 at the end of the D-pathway may be proposed as a proton donor.
Electrometric measurements of charge translocation in the E278Q mutant enzyme strengthen this
assignment, as virtually no charge transfer was detected during A?PR (Paper IV, supplementary
material). The acceptor of the proton in this reaction is most likely some as yet unidentified
group (“pump site”) above the hemes; this cannot be the binuclear center itself since proton
arrival at this center would produce F, which is formed only in the subsequent reaction step. Our
results suggest that the proton transfer from GluI278 to this unidentified location above the heme
groups is responsible for DY generation during A?PR, and that this is the initial step of the
proton pump mechanism.
With these new results, the stoichiometry of charge translocation during each single transition in
the oxidative phase of the catalytic cycle can be deduced. The total amplitude of charge
translocation during the oxidative part of the cycle corresponds to transfer of 3.68 charges across
the membrane (Verkhovsky et al., 1999b). This number includes transfer of an electron from
CuA to  heme a across  0.32  of  the  membrane,  transfer  of  2  protons  across  the  membrane,  and
delivery of 2 protons to the catalytic site for water formation across 0.68 of the membrane. How
is the movement of all of these charges organized during the oxidative part of the catalytic cycle?
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1. The first transition R?A comprises oxygen binding to heme a3 and is electrically
silent.
2. The next step, A?PR includes the transfer of a proton across 0.27 of the membrane,
from GluI278 at the end of the D-pathway to the “pump site”.  There is simultaneous
electron redistribution between hemes a and a3, but this takes place in the plane of the
membrane and is thus electrically silent.
3. During PR?F the charge translocation is due to
· delivery of the a “chemical” proton to the catalytic site across 0.68 of the
membrane;
· electron redistribution between CuA and heme a,  which  gives  a  relative
electrometric amplitude of: 0.32 × 0.6 = 0.19, where 0.6 is the extent of electron
transfer from CuA in this step (Hill, 1991), and 0.32 is the fraction of the total
membrane dielectric crossed by the electron;
· proton pumping events such as reprotonation of GluI278 from the N-side of the
membrane and ejection of a proton that was preloaded to the “pump site”. In total
these events will account for proton transfer across 1 - 0.27 = 0.73 of the
membrane dielectric.
? ? Total: 0.68 + 0.19 + 0.73 = 1.6 charges across the membrane.
4. The final transition in the oxidative part of the cycle, F?OH, consists of delivery of
another chemical proton to the catalytic site across 0.68 of the membrane, electron
transfer from CuA to heme a: 0.32 × 0.4 = 0.13, where 0.32 is the fraction of the total
membrane dielectric crossed by the electron and 0.4 the extent of electron transfer
from CuA, and pumping of a proton across the membrane – 1.0. In total the F?OH
transition is responsible for transfer of 0.68 + 0.13 + 1.0 = 1.81 charges.
5.5 Single Proton Translocation Cycle
In  the  continuous  turnover  regime,  the  catalytic  cycle  of  CcO  consists  of  four  proton
translocation steps (section 5.3; Fig. 10). In each step delivery of an electron to the enzyme starts
a proton pump cycle, which is likely to occur by essentially the same mechanism every time the
electron arrives. In principle, the mechanism of proton translocation during a single pump event
can be studied at any of these steps; however the OH?EH transition is favorable for study due to
high yield (almost 100%) of the OH state in the reaction of the fully-reduced CcO with dioxygen.
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The OH?EH reaction was initiated by electron injection from the photosensitive dye RubiPy
(see section 5.3) and followed by both time-resolved optical spectroscopy and electrometry.
Upon a laser flash, an excited molecule of RubiPy donated an electron to CuA with a time
constant less than 0.5 ms. This reduction of CuA was seen as an unresolved drop of absorption at
820 nm (V, Fig. 2A). This process was followed by electron equilibration (t ~ 10 ms) between
CuA and heme a, in which about 70% of the electron population has been transferred (V, Fig.
2A, 3A). From the amplitude of DY generation measured under the same conditions (V, Fig. 2B)
we can conclude that the 10 ms phase is due to electron transfer only, without any internal proton
translocation. Since the midpoint redox potential (Em) of CuA is about 250 mV (Zickermann et
al., 1995; Gorbikova et al., 2006) it is possible to estimate the Em value for heme a as ~270 mV.
Electron equilibration between CuA and heme a is not coupled to proton uptake (Oliveberg et al.,
1989; Ruitenberg et al., 2000; Siletsky et al., 2004) which accounts for the relatively low
“operational” Em of heme a, which is much lower than the “high asymptotic” Em found in
equilibrium redox titrations (Artzatbanov et al., 1978; Wikström et al., 1981; Blair et al., 1986;
Moody and Rich, 1990; Gorbikova et al, 2006).  However, this potential is still high enough for
heme a to accept part of the electron population from CuA without charge compensation by a
proton. We saw no electron transfer to the binuclear center during the 10 ms phase, which
indicates that the Em values of heme a3 and CuB must be at least as low as 150 mV.
The next phase with t ~ 150 ms consisted of complete oxidation of CuA, and in reoxidation of
about 45% of the population of reduced heme a, by electron transfer to the binuclear center (new
equilibrium: ~40% of electron on heme a, and ~60% on heme a3). Electrometric measurements
showed charge transfer across a fraction of about 0.84 of the membrane dielectric (V, Fig. 2B)
during this phase. Of this, proton transfer accounts for 0.84 – 0.32×0.3 = 0.74, where 0.32 is the
fraction of the total membrane dielectric crossed by the electron and 0.3 is the extent of electron
transfer from CuA. Proton uptake in this phase (as was judged from the amplitude of DY
formation) raises the Em of both hemes to approximately similar values (DEm ~ 10 mV);
unfortunately, it is not possible to make a quantitative assessment of their Em values at this point
in the reaction because our internal redox indicator - CuA - is completely oxidized. However, we
can conclude that the potentials of the two hemes are both about 370 mV, which corresponds to
the “high-asymptotic” Em value measured in anaerobic redox titrations where there is
equilibrium with protons (Blair et al., 1986; Wikström et al., 1981; Gorbikova et al., 2006). The
intrinsic electron equilibration between heme a3 and heme a occurs in about 1 ns (Verkhovsky et
al., 2001a; Pilet et al., 2004) in agreement with the short edge-to-edge distance between the
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hemes (Page et al., 1999). This rate is however much faster than the observed electron
equilibration between these centers during OH?EH (150 ms), which also indicates involvement
of protons in this reaction step. The acceptor of the electron during 150 ms phase can be
identified from the kinetic spectra of this and the following phases, after subtracting the
contribution from oxidation of heme a (V, Fig. 3C). Based on reversibility of changes in the 560-
620 nm spectral region during the 150 ms and the subsequent 800 ms  phases  we  were  able  to
assign heme a3 as the electron acceptor during the 150 ms phase.
The last phase observed by optical absorbance has t ~ 800 ms; here heme a becomes completely
oxidized by electron transfer to the binuclear center. The final acceptor of the electron can be
deduced from the spectral difference between the final state and the initial state before electron
injection (V, Fig. 3B). The only feature seen in the difference spectrum is a blue shift of the 665-
nm charge transfer band that can be ascribed to reduction of CuB.  Because  after  this  phase  all
redox centers except CuB are oxidized we were able to estimate the Em value of CuB as more than
100 mV higher than that of heme a. Based on electrometric results, the 800 ms phase is coupled
to proton transfer across a  ~0.60 fraction of the membrane.
The 150 and 800 ms phases together make the largest contribution to the total DY generation in
this  reaction,  and  it  is  these  two  phases  where  uptake  and  transfer  of  pumped  and  substrate
protons takes place. The fate of the proton which is being transferred at each phase can be
established based on an estimation of the Em values of the redox cofactors in the binuclear center.
Arrival of the pumped proton at the “pump site” in proximity to the binuclear center should
increase the Em of the binuclear center much less than the entry of the “chemical” proton directly
into the binuclear center. Based on this logic it is possible to assign the 150 ms phase to uptake of
the pumped proton from the N-side of the membrane, and the 800 ms phase to uptake of the
substrate proton.
Interestingly, in addition to the three phases that are coupled to the electron transfer reaction, the
kinetics of DY generation included an extra component that was not detected in the optical
measurements. This phase has t ~ 2.6 ms and is linked to transfer of 0.32 charges across the
membrane dielectric. Most likely this phase is due to relaxation of the protein and release of the
pumped proton from the “pump site” towards the P-side of the membrane.
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Based on the data obtained we can propose a possible mechanism of proton pumping by CcO.
During single-electron reduction of the OH state of CcO, the electron first enters the CuA center.
In the next phase the electron equilibrates between CuA and heme a, with t ~ 10 ms (V, Fig. 4,
??II). The arrival of electron on heme a raises the pKa of a yet unidentified “pump site” above
the heme groups, which takes up a proton with t ~ 150 ms (V, Fig. 4, II?III). The protonation of
the “pump site” occurs from the conserved GluI278(242) via a chain of water molecules by the
Grotthuss mechanism (de Grotthuss, 1806&2006; Nagle and Morowitz, 1978; Agmon, 1995)
(Fig. 7). Three or four water molecules are predicted to reside inside the hydrophobic cavity
between the glutamate, the D-propionate of heme a3, and the binuclear center (Riistama et al.,
1997; Zheng et al., 2003). These water molecules are sensitive to the redox-state-dependent
electric field between heme a and the binuclear center, and arrange themselves into two different
configurations for proton transfer (Wikström et al., 2003). When the binuclear center is oxidized
and the electron is on heme a, the array of water molecules is oriented towards the D-propionate
of heme a3 (“pump site” direction); however this array switches towards the binuclear center (the
direction for chemical reaction) after reduction of the binuclear center from heme a. The rate-
limiting protonation of the “pump site” raises the Em of both hemes, and leads to further electron
equilibration between CuA and the two hemes in the same time window (V, Fig. 4, III?IV). At
the end of the 150 ms phase CuA is fully oxidized, while heme a and heme a3 have 40% and 60%
of the injected electron population respectively. In addition, the 150 ms phase includes
reprotonation of GluI278 from the N-side of the membrane via the proton conducting D-
pathway.
In the next phase (t ~ 800 ms), transfer of a substrate proton to the OH- ligand of CuB (Fann et
al., 1995) raises the Em of  CuB to  a  value  much  higher  than  those  of  all  other  redox  centers,
which induces ultimate movement of the injected electron to the CuB center (V, Fig. 4, IV?V).
During  the  last  step  (t ~ 2.6 ms) of the single proton pump cycle, the proton, which has been
“preloaded” into the “pump site”, is expelled towards the P-side of the membrane due to
electrostatic repulsion from the substrate proton.
It seems feasible that the mechanism of proton translocation during PM?F, F?OH, and EH?R
is essentially the same as in the OH?EH transition with the only difference being the final
destination of the injected electron. After oxygen activation, CcO has 4 high potential acceptors
that are sequentially filled with electrons during each of the pumping transition steps. Thus, the
SINGLE PROTON TRANSLOCATION CYCLE
68
sequence of events shown in Figure 4 (Paper V) would be repeated every time an electron enters
the CuA site.  In each case the electron travels from cytochrome c to  CuA, and subsequently
through heme a to the binuclear center, driving proton pumping across the membrane.
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6. SUMMARY
In this work we have applied a complex approach using a variety of different techniques to study
the properties and the mechanism of proton translocation by the terminal oxidases. The
combination of direct measurements of pH changes during catalytic turnover, time-resolved
potentiometric electrometry and optical spectroscopy, made it possible to obtain valuable
information about various aspects of oxidase functioning.
We compared oxygen binding properties of oxidases from the distinct heme-copper and
cytochrome bd families and found that cytochrome bd indeed has a high affinity for oxygen,
which is 3 orders of magnitude higher than that of CcO. Interestingly, the difference between
CcO and cytochrome bd is not only in higher affinity of the latter to oxygen, but also in the way
that each of these enzymes traps oxygen during catalysis. CcO traps oxygen kinetically - the
molecule of bound dioxygen is rapidly reduced before it can dissociate. In contrast cytochrome
bd employs an alternative mechanism of oxygen trapping - part of the redox energy is invested
into tight oxygen binding, and the price paid for this is the lack of proton pumping.
A single cycle of oxygen reduction to water is characterized by translocation of four protons
across the membrane. Our results make it possible to assign the pumping steps to discrete
transitions of the catalytic cycle and indicate that during in vivo turnover  of  the  oxidase  these
four protons are transferred, one at a time, during the ??F, ??OH, OH?EH, and EH?R
transitions. At the same time, each individual proton translocation step in the catalytic cycle is
not just a single reaction catalyzed by CcO, but rather a complicated sequence of interdependent
electron and proton transfers. We assume that each single proton translocation cycle of CcO is
assured by internal proton transfer from the conserved GluI278(242) to an as yet unidentified
“pump site” above the hemes. Delivery of a proton to the “pump site” serves as a driving
reaction that forces the proton translocation cycle to continue.
Based on our study of the electron backflow reaction we conclude that it is important to be
particularly cautious about comparison of results that are obtained with membrane proteins under
different environmental conditions, especially when comparing the results from reconstituted and
soluble systems, because it is possible that some functional properties may be altered.
ACKNOWLEDGEMENTS
70
7. ACKNOWLEDGEMENTS
This study was performed in the Helsinki Bioenergetics Group at the Institute of Biotechnology
and at the Division of Biochemistry, Faculty of Biosciences, University of Helsinki. The
Academy  of  Finland,  the  University  of  Helsinki,  Biocentrum  Helsinki,  and  the  Sigrid  Jusélius
Foundation are kindly acknowledged for financial support of the work.
I would like to thank my academic advisers Dr. Michael Verkhovsky and Prof. Mårten Wikström
sincerely for providing me continuous support, help, and the great opportunity to work in their
team over these years. Their enthusiastic approach was extremely encouraging.
I would like to express my gratitude to all past and present members of the Helsinki
Bioenergetics Group for their invaluable assistance, enjoyable discussions, company in trips,
banters and inspiration. In particular, I especially would like thank Audrius Jasaitis, Dima Bloch,
Anne Tuukkanen, Anne Puustinen, Camilla Ribacka for collaboration; Pamela David, Liliya
Euro, Mika Molin, Vivek Sharma, and Ville Kaila for being able to share the office space with
me; Marina Verkhovskaya, Virve Rauhamäki, Elena Gorbikova, Liisa Laakkonen, Markus
Kaukonen for kind and efficient help in the lab premises and in silico matters. The huge special
thank is to my external co-authors - Vitaliy Borisov, and Alexander Konstantinov from the
Moscow State University.
I thank the reviewers, Prof. Ilmo Hassinen and Prof. Joel Morgan for critical reading of the thesis
and their constructive comments, which I found extremely valuable.
The kindest appreciation is to our lab technicians and research assistants Eija Haasanen, Tarja
Salojärvi, and Anne Hakonen for their excellent technical expertise. Also I want to express a
special  thank  is  to  our  former  secretary  Satu  Sankkila  who  was  solving  all  practical  problems
with confidence, and took a good care of me from my first days in Finland.
I deeply thank all my friends who are now all other the world but still are able to share with me
their kindness and friendship. Especially I would like to thank those who are now in Finland -
Tolya Verkhovsky, Rasa Gabrenaite-Verkhovskaya, Evgeny Kulesskiy, Alexey Adamov, Niina
Juuti, Dima Tisnek, Petteri Kuuskoski, Dima Shchigel, and my other friends for the great time
and the lighting up the dull autumn days.
Finally and most importantly, I would like to thank my family. I am sincere grateful to my wife
Katya and to my parents Galina and Nikolay for their love. This work would never have been
completed without their support.
Ilya Belevich,
Helsinki, September 2007
REFERENCES
71
8. REFERENCES
Aasa, R., Albracht, S.P.J., Falk, K-E., Lanne, B., and Vanngård, T. (1976) // Biochim. Biophys.
Acta, 422, 260-272.
Abramson, J., Riistama, S., Larsson, G., Jasaitis, A., Svensson-Ek, M., Laakkonen, L.,
Puustinen, A., Iwata, S. and Wikström, M. (2000) // Nat. Struct. Biol., 7, 910-917.
Agmon, N. (1995) // Chem. Phys. Lett., 244, 456-462.
Alben, J.O., Moh, P.P., Fiamingo, F.G., and Altschuld, R.A. (1981) // Proc. Natl. Acad. Sci.
USA, 78, 234-237.
Anraku, Y., and Gennis, R.B. (1987) // Trends Biochem. Sci., 12, 262-266.
Antalis, T.M., and Palmer, G. (1982) // J. Biol. Chem., 257, 6194-6206.
Antholine, W.E., Kastrau, D.H.W., Steffens, G.C.M., Buse, G., Zumft, W.G., and Kroneck,
P.M.H. (1992) // Eur. J. Biochem., 209, 875-881.
Antonini, E., Brunori, M., Colosimo, A., Greenwood, C., and Wilson, M.T. (1977) // Proc. Natl.
Acad. Sci. USA, 74, 3128-3132.
Arnold, S., Goglia, F., and Kadenbach, B. (1998) // Eur. J. Biochem., 252, 325-330.
Artzatbanov, V.Yu., Konstantinov, A.A., and Skulachev, V.P. (1978) // FEBS Lett., 78, 180-185.
Babcock, G.T., Vickery, L.E., and Palmer, G. (1976) // J. Biol. Chem., 251, 7907-7919.
Babcock, G.T., Callahan, P.M., Ondrias, M.R., and Salmeen, I. (1981) // Biochemistry, 20, 959-
966.
Babcock, G.T., and Callahan, P.M. (1983) //  Biochemistry, 22, 2314-2319.
Babcock, G.T., and Wikström, M. (1992) // Nature, 356, 301-309.
Baker, G.M., Noguchi, M., and Palmer, G. (1987) // J. Biol. Chem., 262, 595-604.
Beinert, H., Griffiths, D.E., Wharton, D.C., and Sands, R.H. (1962) // J. Biol. Chem., 237, 2337-
2346.
Beinert, H., Hansen, R.E., and Hartzell, C.R. (1976) // Biochim. Biophys. Acta, 423, 339-355.
Berry, E.A., and Trumpower, B. (1985) // J. Biol. Chem., 260, 2458-2467.
Berry, S., Schneider, D., Vermaas, W.F.J., and Rönger, M. (2002) // Biochemistry, 41, 3422-
3429.
Bickar, D., Bonaventura, J., and Bonaventura, C. (1982) // Biochemistry, 21, 2661-2666.
Blackmore, R.S., Greenwood, C., and Gibson, Q.H. (1991) // J. Biol. Chem., 266, 19245-19249.
Blair, D.F., Witt, S.N., and Chan, S.I. (1985) // J. Am. Chem. Soc., 107, 7389-7399.
Blair, D.F., Ellis, W.R.Jr., Wang, H., Gray, H.B., and Chan, S.I. (1986) // J. Biol. Chem., 261,
11524-11537.
Boelens, R., and Wever, R. (1979) // Biochim. Biophys. Acta, 547, 296-310.
Bogachev, A.V., Murtazina, R.A., and Skulachev V.P. (1996) // J. Bacteriol., 178, 6233-6237.
Borisov, V.B., Liebl, U., Rappaport, F., Martin, J.-L., Zhang, J., Gennis, R.B., Konstantinov,
A.A., and Vos, M.H. (2002) // Biochemistry, 41, 1654-1662.
Brzezinski, P. (1996) // Biochemistry, 35, 5611-5615.
Brzezinski, P., and Larsson, G. (2003) // Biochim. Biophys. Acta, 1605, 1-13.
Brändén, G., Brändén, M., Schmidt, B., Mills, D.A., Ferguson-Miller, S., and Brzezinski, P.
(2005) // Biochemistry, 44, 10466-10474.
Brändén, M., Sigurdson, H., Namslauer, A., Gennis, R.B., Ädelroth, P., and Brzezinski, P.
(2001) // Proc. Natl. Acad. Sci. USA, 98, 5013-5018.
Brändén, M., Tomson, F., Gennis, R.B., and Brzezinski, P. (2002) // Biochemistry, 41, 10794-
10798.
Brändén, M., Namslauer, A., Hansson, O., Aasa, R., and Brzezinski, P. (2003) // Biochemistry,
42, 13178-13184.
Buse, G., Soulimane, T., Dewor, M., Meyer, H.E., and Blüggel, M. (1999) // Prot. Sci., 8, 985-
990.
REFERENCES
72
Bushnell, G.W., Louie, G.V., and Brayer G.D. (1990) // J. Mol. Biol., 214, 585-595.
Calhoun, M.W., Thomas, J.W., and Gennis R. (1994) // Trends Biochem. Sci., 19, 325-330.
Callahan, P.M., and Babcock, G.T. (1983) // Biochemistry, 22, 452-461.
Cao, J., Shapleigh, J., Gennis, R., Revzin, A., and Ferguson-Miller, S. (1991) // Gene, 101, 133-
137.
Cao, J., Hosler, J., Shapleigh, J., Revzin, A., and Ferguson-Miller, S. (1992) // J. Biol. Chem.,
267, 24273-24278.
Capaldi, R.A. (1990) // Annu.Rev.Biochem., 59, 569-596.
Capitanio, N., Vygodina, T.V., Capitanio, G., Konstantinov, A.A., Nicholls, P., and Papa, S.
(1997) // Biochim. Biophys. Acta, 1318, 255-265.
Carroll, J., Shannon, R.J., Fearnley, I.M., Walker, J.E., and Hirst, J. (2002) // J. Biol. Chem., 277,
50311– 50317.
Casey, R.P., Chappell, J.B., and Azzi, A. (1979) // Biochem. J., 182, 149-156.
Caughey, W.S., Smythe, G.A., O’Keeffe, D.H., Maskasky, J.E., and Smith, M.L. (1975) // J.
Biol. Chem., 250, 7602-7622.
Chance, B., Saronio, C., and Leigh, J.S.Jr. (1975) // J. Biol. Chem., 250, 9226-9237.
Crofts, A.R. (2004) // Annu. Rev. Physiol., 66, 689-733.
de Grotthuss, C.J.T. (1806) // Ann. Chim. (Paris), LVIII, 54-74.
de Grotthuss, C.J.T. (2006) // Biochim. Biophys. Acta, 1757, 871-875.
D’mello, R., Hill, S., and Poole, R.K. (1996) // Microbiology, 142, 755-763.
Drachev, L.A., Jasaitis, A.A., Kaulen, A.D., Kondrashin, A.A., Liberman, E.A., Nemecek, I.B.,
Ostroumov, S.A., Semenov, A.Y., and Skulachev, V.P. (1974) // Nature, 249, 321-324.
Drachev, L.A., Kaulen, A.D., Semenov, A.Y., Severina, I.I., and Skulachev, V.P. (1979) // Anal.
Biochem., 96, 250-262.
Draghi, F., Miele, A.E., Traveglini-Allocatelli, C., Vallone, B., Brunori, M., Gibson, Q.H., and
Olson, J.S. (2002) // J. Biol. Chem., 277, 7509-7519.
Dutton, P.L., and Wilson, D.F. (1974) // Biochim. Biophys. Acta, 346, 165-212.
Einarsdóttir, Ó., and Caughey, W.S. (1985) //  Biochem. Biophys. Res. Commun., 129, 840-847.
Einarsdóttir, Ó., Georgiadis, K.E., and Sucheta, A. (1995) // Biochemistry, 34, 496-508.
Fabian, M., Wong, W.W., Gennis, R.B., and Palmer, G. (1999) // Proc. Natl. Acad. Sci. USA, 96,
13114-13117.
Fann, Y.C., Ahmed, I., Blackburn, N.J., Boswell, J.S., Verkhovskaya, M.L., Hoffman, B.M., and
Wikström, M. (1995) // Biochemistry, 34, 10245-10255.
Faxén, K., Gilderson, G., Ädelroth, P., and Brzezinski, P. (2005) // Nature, 437, 286-289.
Ferguson-Miller, S., Brautigan, D.L., and Margoliash, E. (1978) // J. Biol. Chem., 253, 149-159.
Fetter, J.R., Qian, J., Shapleigh, J., Thomas, J.W., Garcia-Horsman, A., Schmidt, E., Hosler, J.,
Babcock, G.T., Gennis, R.B., and Ferguson-Miller, S. (1995) // Proc. Natl. Acad. Sci. USA,
92, 1604-1608.
Fry, H.C., Hoertz, P.G., Wasser, I.M., Karlin, K.D., and Meyer, G.J. (2004) // J. Am. Chem. Soc.,
126, 16712-16713.
Fuller, S.D., Darley-Usmar, V.M., and Capaldi, R.A. (1981) // Biochemistry, 20, 7046-7053.
Garcia-Horsman, J.A., Barquera, B., Rumbley, J., Ma., J., and Gennis, R. (1994) // J. Bacteriol.,
176, 5587-5600.
Gelles, J., Blair, D.F., and Chan, S.I. (1986) // Biochim. Biophys. Acta, 853, 205-236.
Geren, L.M., Beasley, J.R., Fine, B.R., Saunders, A.J., Hibdon, S., Pielak, G.J., Durham, B., and
Millet, F. (1995) // J. Biol. Chem., 270, 2466-2472.
Gibson, Q.H., and Greenwood, C. (1963) // Biochem. J., 86, 541-555.
Gibson, Q.H., and Greenwood, C. (1964) // J. Biol. Chem., 239, 586-590.
Gnaiger, E. (2003) // Adv. Exp. Med. Biol., 543, 39-55.
Gorbikova, E.A., Vuorilehto, K., Wikström, M., and Verkhovsky, M.I. (2006) // Biochemistry,
45, 5641-5649.
REFERENCES
73
Gray, H.B., and Winkler, J.R. (1996) // Annu. Rev. Biochem., 65, 537-561.
Green, G.N., Lorence, R.M., and Gennis, R.B. (1986) // Biochemistry, 25, 2309-2314.
Hallén, S., Brzezinski, P., and Malmström, B.G. (1994) // Biochemistry, 33, 1467-1472.
Haltia, T., Finel, M., Harms, N., Nakari, T., Raitio, M., Wikström, M., and Saraste, M. (1989) //
EMBO J., 8, 3571-3579.
Haltia, T., Saraste, M., and Wikström, M. (1991) // EMBO J., 10, 2015-2021.
Haltia, T., Semo, N., Arrondo, J.L.R., Goñi, F.M., and Freire, E. (1994) // Biochemistry, 33,
9731-9740.
Han, S., Ching, Y.-C., and Rousseau, D.L. (1990a) // Proc. Natl. Acad. Sci. USA, 87, 2491-2495.
Han, S., Ching, Y.-C., and Rousseau, D.L. (1990b) // Proc. Natl. Acad. Sci. USA, 87, 8408-8412.
Harrenga, A. and Michel, H.(1999) // J. Biol. Chem., 274, 33296-33299.
Hazzard, J.T., Rong, S-Y., and Tollin, G. (1991) // Biochemistry, 30, 213-222.
Hendler, R.W., Pardhasaradhi, K., Reynafarje, B., and Ludwig, B. (1991) // Biophys. J., 60, 415-
423.
Hendriks, J.H.M., Jasaitis, A., Saraste, M., and Verkhovsky, M.I. (2002) // Biochemistry, 41,
2331-2340.
Hill, B.C. (1991) // J. Biol. Chem., 266, 2219-2226.
Hill, B.C. (1994) // J. Biol. Chem., 269, 2419-2425.
Hill, B.C., and Greenwood, C. (1983) // Biochem. J., 215, 659-667.
Hill, B.C., and Greenwood, C. (1984) // Biochem. J., 218, 913-921.
Hill, B.C., Hill, J.J., and Gennis, R.B. (1994) // Biochemistry, 33, 15110-15115.
Hill, S., Viollet, S., Smith, A.T., and Anthony, C. (1990) // J. Bacteriol., 172, 2071-2078.
Hinchliffe, P., and Sazanov L.A. (2005) // Science, 309, 771-774.
Hinkle, P.C. (1979) // Methods Enzymol., 55, 748-751.
Hirst, J. (2005) // Biochem. Soc. Trans., 33(3), 525-529.
Hofacker, I., and Schulten, K. (1998) // Proteins: Structure, Function and Genetics, 30, 100-107.
Horie, S., and Morrison, M. (1963) // J. Biol. Chem., 238, 1855-1860.
Horsefield, R., Iwata S., and Byrne., B. (2004) // Curr. Protein Pept. Sci., 5, 107-118.
Hosler, J.P., Ferguson-Miller, S., Calhoun, M.W., Thomas, J.W., Hill, J., Lemieux, L, Ma, J.,
Georgiou, C., Fetter, J., Shapleigh, J., Tecklenburg, M.M.J., Babcock, G.T., and Gennis, R.
(1993) // J. Bioenerg. Biomembr., 25, 121-136.
Hosler, J.P., Espe, M.P., Zhen, Y., Babcock, G.T., Ferguson-Miller, S. (1995) // Biochemistry,
34, 7586-7592.
Hosler, J.P., Shapleigh, J.P., Mitchell, D.M., Kim, Y., Pressler, M.A., Georgiou, C., Babcock,
G.T., Alben, J.O., Ferguson-Miller, S., and Gennis, R.B. (1996) // Biochemistry, 35, 10776-
10783.
Hunsicker-Wang, L.M., Pacoma, R.L., Chen, Y., Fee, J.A. and Stout, C.D. (2005) // Acta
Crystallogr., Sect.D,  61, 340-343.
Iwata, S., Ostermeier, C., Ludwig, B., and Michel, H. (1995) // Nature, 376, 660-669.
Jancura, D., Berka, V., Antalik, M., Bagelova, J., Gennis, R.B., Palmer, G., and Fabian, M.
(2006) // J. Biol. Chem., 281, 30319-30325.
Jasaitis, A., Verkhovsky, M.I., Morgan, J.E., Verkhovskaya, M.L., and Wikström, M. (1999) //
Biochemisty, 38, 2697-2706.
Jasaitis, A., Backgren, C., Morgan, J.E., Puustinen, A., Verkhovsky, M.I., and Wikström, M.
(2001) // Biochemistry, 40, 5269-5274.
Joseph-Horne, T., Hollomon, D.W., and Wood, P.M. (2001) // Biochim. Biophys. Acta, 1504,
179-195.
Jünemann, S., Butterworth, P.J., and Wrigglesworth, J.M. (1995) // Biochemistry, 34, 14861-
14867.
Kadenbach, B., and Merle, P. (1981) // FEBS Lett., 135, 1-11.
REFERENCES
74
Kadenbach, B., Hüttemann, M., Arnold, S., Lee, I., and Bender, E. (2000) // Free Radical Biol.
Med., 29, 211-221.
Kannt, A., Lancaster, C.R.D., and Michel, H. (1998) // J. Bioenerg. Biomembr., 30, 81-87.
Kannt, A., Pfitzner, U., Ruitenberg, M., Hellwig, P., Ludwig, B., Mäntele, W., Fendler, K., and
Michel, H. (1999) // J. Biol. Chem., 274, 37974-37981.
Karlsson, B., and Andreasson, L.-E. (1981) // Biochim. Biophys. Acta, 635, 73-81.
Karlsson, B., Aasa, R., Vänngård, T., and Malmström, B.G. (1981) // FEBS Lett., 131, 186-188.
Karpefors, M., Ädelroth, P., Zhen, Y., Ferguson-Miller, S., and Brzezinski, P. (1998) // Proc.
Natl. Acad. Sci. USA, 95, 13606-13611.
Karpefors, M., Ädelroth, P., Namslauer, A., Zhen, Y., and Brzezinski, P. (2000) // Biochemistry,
39, 14664-14669.
Keilin, D. (1925) // Proc. R. Soc. Lond. B Biol. Sci., 98, 312-339.
Keilin, D. (1927) // Nature, 119, 670-671.
Kelly, M.J.S., Poole, R.K., Yates, M.G., and Kennedy, C. (1990) // J. Bacteriol., 172, 6010-
6019.
Kelly, M., Lappalainen, P., Talbo, G., Haltia, T., van der Oost, J., and Saraste, M. (1993) // J.
Biol. Chem., 268, 16781-16787.
Kirichenko, A., Vygodina, T., Mkrtchyan, H.M., and Konstantinov, A. (1998) // FEBS Lett., 423,
329-333.
Kita, K., Konishi, K., and Anraku, Y. (1984) // J. Biol. chem.., 259, 3375-3381.
Kobayashi, K., Une, H., and Hayashi, K. (1989) // J. Biol. Chem., 264, 7976-7980.
Kolonay, J.F.Jr., Moshiri, F., Gennis, R.B., Kaysser, T.M., and Maier, R.J. (1994) // J.
Bacteriol., 176, 4177-4181.
Konstantinov, A.A., Siletsky, S., Mitchell, D., Kaulen, A., and Gennis, R.B. (1997) // Proc. Natl.
Acad. Sci. USA, 94, 9085-9090.
Krab, K., and Wikström, M. (1978) // Biochim. Biophys. Acta, 504, 200-214.
Kroneck, P.M.H., Antholine, W.E., Kastrau, D.H.W., Buse, G., Steffens, G.C.M., and Zumft,
W.G. (1990) // FEBS Lett., 268, 274-276.
LaMarche, A.E.P., Abate, M.I., Chan, S.H.P., and Trumpower, B.L. (1992) // J. Biol. Chem.,
267, 22473-22480.
Lanyi, J.K. (2004) // Mol. Membr. Biol., 21, 143-150.
Lappalainen, P., Aasa, R., Malmström, B.G., and Saraste, M. (1993) // J. Biol. Chem., 268,
26416-26421.
Larsen, R.W., Pan, L.-P., Musser, S.M., Li, Z., and Chan, S.I. (1992) // Proc. Natl. Acad. Sci.
USA, 89, 723-727.
Lee, H., Das, T.K., Rousseau, D.L., Mills, D., Ferguson-Miller, S., and Gennis, R.B. (2000) //
Biochemistry, 39, 2989-2996.
Lee, A., Kirichenko, A., Vygodina, T., Siletsky, S.A., Das, T.K., Rousseau, D.L., Gennis, R.,
and Konstantinov, A. (2002) // Biochemistry, 41, 8886-8898.
Lemberg, R. (1962) Action of alkali on cytochrome oxidase. // Nature, 193, 373-374.
Liao, G.-L., and Palmer, G. (1996) // Biochim. Biophys. Acta, 1274, 109-111.
Lindsay, J.G., Owen, C.S., and Wilson, D.F. (1975) // Archs. Biochem. Biophys., 169, 492-505.
Lorence, R.M., and Gennis, R.B. (1989) // J. Biol. Chem., 264, 7135-7140.
Ma, J., Tsatsos, P.H., Zaslavsky, D., Barquera, B., Thomas, J.W., Katsonouri, A., Puustinen, A.,
Wikström, M., Brzezinski, P., Alben, J.O., and Gennis, R.B. (1999) // Biochemistry, 38,
15150-15156.
Malatesta, F., Sarti, P., Antonini, G., Vallone, B., and Brunori, M. (1990) // Proc. Natl. Acad.
Sci. USA, 87, 7410-7413.
Malmström, B.G., and Aasa, R. (1993) // FEBS Lett., 325, 49-52.
Marcus, R.A., and Sutin, N. (1985) // Biochim. Biophys. Acta, 811, 265-322.
Mayo, S.L., Ellis, W.R.Jr., Crutchley, R.J., and Gray, H.B. (1986) // Science, 233, 948-952.
REFERENCES
75
McCauley, K.M., Vrtis, J.M., Dupont, J., and van der Donk, W.A. (2000) // J. Am. Chem. Soc.,
122, 2403-2404.
Michel, H. (1998) // Proc. Natl. Acad. Sci. USA, 95, 12819-12824.
Miller, M.J., and Gennis, R.B. (1985) // J. Biol. Chem., 260, 14003-14008.
Mitchell, P. (1961) // Nature, 191, 144-184.
Mitchell, P. (1976) // J. Theor. Biol, 62, 327-367.
Mitchell, P. (1988) // Ann. N. Y. Acad. Sci., 550, 185-198.
Mitchell, R., Mitchell, P., and Rich, P.R. (1991) // FEBS Lett., 280, 321-324.
Mitchell, R., and Rich, P.R. (1994) // Biochim. Biophys. Acta, 1186, 19-26.
Moody, A.J., and Rich, P.R. (1990) // Biochim. Biophys. Acta, 1015, 205-215.
Moody, A.J., Cooper, C.E., and Rich, P.R. (1991a) // Biochim. Biophys. Acta, 1059, 189-207.
Moody, A.J., Brandt, U., and Rich, P.R. (1991b) // FEBS Lett., 293, 101-105.
Morgan, J.E., Li, P.M., Jang, D.-J., El-Sayed, M.A., and Chan, S.I. (1989) // Biochemistry, 28,
6975-6983.
Morgan, J.E., Verkhovsky, M.I., Puustinen, A., and Wikström, M. (1993) // Biochemistry, 32,
11413-11418.
Morgan, J.E., Verkhovsky, M.I., and Wikström, M. (1994) // J. Bioenerg. Biomembr., 26, 599-
608.
Morgan, J.E., Verkhovsky, M.I., and Wikström, M. (1996) // Biochemistry, 35, 12235-12240.
Morgan, J.E., Verkhovsky, M.I., Palmer, G., and Wikström, M. (2001) // Biochemistry, 40,
6882-6892.
Moser, C.C., Keske, J.M., Warncke, K., Farid, R.S., and Dutton, P.L. (1992) // Nature, 355, 796-
802.
Muramoto, K., Hirata, K., Shinzawa-Itoh, K., Yoko-o, S., Yamashita, E., Aoyama, H.,
Tsukihara, T., and Yoshikawa, S. (2007) // Proc. Natl. Acad. Sci. USA, 104, 7881-7886.
Nagle, J.F., and Morowitz, H.J. (1978) // Proc. Natl. Acad. Sci. USA, 75, 298-302.
Nilsson, T. (1992) // Proc. Natl. Acad. Sci. USA, 89, 6497-6501.
Ogura, T., Takahashi, S., Shinzawa-Itoh, K., Yoshikawa, S., and Kitagawa, T. (1990) // J. Biol.
Chem., 265, 14721-14723.
Oliveberg, M., Brzezinski, P., and Malmström, B.G. (1989) // Biochim. Biophys. Acta, 977, 322-
328.
Oliveberg, M., and Malmström, B.G. (1991) // Biochemistry, 30, 7053-7057.
Oliveberg, M., Hallén, S., and Nilsson, T. (1991) // Biochemistry, 30, 436-440.
Oliveberg, M., and Malmström, B.G. (1992) // Biochemistry, 31, 3560-3563.
Orii, Y. (1988) // Ann. N.Y. Acad. Sci., 550, 105-117.
Ostermeier, C., Harrenga, A., Ermler, U. and Michel, H. (1997) // Proc. Natl. Acad. Sci. USA,
94, 10547-10553.
Page, C.C., Moser, C.C., Chen, X., and Dutton, P.L. (1999) // Nature, 402, 47-52.
Papa, S., Capitanio, N., and Villani, G. (1998) // FEBS Lett., 439, 1-8.
Pelletier, H., and Kraut, J. (1992) // Science, 258, 1748-1755.
Petersen, L.C., Nicholls, P., and Degn, H. (1976) // Biochim. Biophys. Acta, 452, 59-65.
Pezeshk, A., Torres, J., Wilson, M.T., and Symons, M.C.R. (2001) // J. Inorg. Biochem., 83,
115-119.
Pfitzner, U., Odenwald, A., Ostermann, T., Weingard, L., Ludwig, B., and Richter, O.-M.H.
(1998) //  J. Bioenerg. Biomembr., 30, 89-97.
Pfitzner, U., Kirichenko, A., Konstantinov, A.A., Mertens, M., Wittershagen, A., Kolbesen,
B.O., Steffens, G.C.M., Harrenga, A., Michel, H., and Ludwig, B. (1999) // FEBS Lett.,
456, 365-369.
Pilet, E., Jasaitis, A., Liebl, U., and Vos, M.H. (2004) // Proc. Natl. Acad. Sci. USA, 101, 16198-
16203.
Poole, R.K. (1983) // Biochim. Biophys. Acta, 726, 205-243.
REFERENCES
76
Popovi?, D.M., and Stuchebrukhov, A.A. (2004) // FEBS Lett., 566, 126-130.
Proshlyakov, D.A., Pressler, M.A., and Babcock, G.T. (1998) // Proc. Natl. Acad. Sci. USA, 95,
8020-8025.
Proshlyakov, D.A., Pressler, M.A., DeMaso, C., Leykam, J.F., DeWitt, D.L., and Babcock, G.T.
(2000) // Science, 290, 1588-1591.
Puustinen, A., Finel, M., Virkki, M., and Wikström, M. (1989) // FEBS Lett., 249, 163-167.
Puustinen, A., Finel, M., Haltia, T., Gennis, R.B., and Wikström, M. (1991) // Biochemistry, 30,
3936-3942.
Puustinen, A., and Wikström, M. (1999) // Proc. Natl. Acad. Sci. USA, 96, 35-37.
Qin, L., Hiser, C., Mulichak, A., Garavito, R.M., and Ferguson-Miller, S. (2006) // Proc. Natl.
Acad. Sci. USA, 103, 16117-16122.
Raitio, M., Tuulikki, J., and Saraste, M. (1987) // EMBO J., 6, 2825-2833.
Rauhamäki, V., Baumann, M., Soliymani, R., Puustinen, A., and Wikström, M. (2006) // Proc.
Natl. Acad. Sci. USA, 103, 16135-16140.
Reinhammar, B., Malkin, R., Jensen, P., Karlsson, B., Andreasson, L.-E., Aasa, R., Vänngård,
T., and Malmström, B.G. (1980) // J. Biol. Chem., 255, 5000-5003.
Ribacka, C., Verkhovsky, M.I., Belevich, I., Bloch, D.A., Puustinen, A., Wikström, M. (2005) //
Biochemistry, 44, 16502-16512.
Rice, C.R., and Hempfling, W.P. (1978) // J. Bacteriol., 134, 115-124.
Rich, P.R., Jünemann, S., and Meunier, B. (1998) // J. Bioenerg. Biomembr., 30, 131-138.
Rieder, R., and Bosshard, H.R. (1980) // J. Biol. Chem., 255, 4732-4739.
Rigaud, J.-L., Pitard, B., and Levy, D. (1995) // Biochim. Biophys. Acta, 1231, 223-246.
Riistama, S., Puustinen, A., Garcia-Horsman, A., Iwata, S., Michel, H., and Wikström, M.
(1996) // Biochim. Biophys. Acta, 1275, 1-4.
Riistama, S., Hummer, G., Puustinen, A., Dyer, R.B., Woodruff, W.H., and Wikström, M.
(1997) // FEBS Lett., 414, 275-280.
Riistama, S., Laakkonen, L., Wikström, M., Verkhovsky, M.I., and Puustinen, A. (1999) //
Biochemistry, 38, 10670-10677.
Riistama, S., Puustinen, A., Verkhovsky, M., Morgan, J.E., and Wikström, M. (2000a) //
Biochemistry, 39, 6365-6372.
Riistama, S., Verkhovsky, M.I., Laakkonen, L., Wikström, M and Puustinen, A. (2000b) //
Biochim. Biophys. Acta, 1456, 1-4.
Rousseau, D.L., Ching, Y.-C., and Wang, J. (1993) // J. Bioenerg. Biomembr., 25, 165-176.
Ruitenberg, M., Kannt, A., Bamberg, E., Ludwig, B., Michel, H., and Fendler, K. (2000) // Proc.
Natl. Acad. Sci. USA, 97, 4632-4636.
Ruitenberg, M., Kannt, A., Bamberg, E., Fendler, K., and Michel H. (2002) // Nature, 417, 99-
102.
Saiki, K., Mogi, T., Ogura, K., and Anraku, Y. (1993) // J. Biol. Chem., 268, 26041-26045.
Salomonsson, L., Lee, A., Gennis, R.B., and Brzezinski, P. (2004) // Proc. Natl. Acad. Sci. USA,
101, 11617-11621.
Saraste, M. (1990) // Q. Rev. Biophys., 23, 331-366.
Saraste, M. (1999) // Science, 283, 1488-1493.
Schmidt, B., McCracken, J., and Ferguson-Miller, S. (2003) // Proc. Natl. Acad. Sci. USA, 100,
15539-15542.
Seelig, A., Ludwig, B., Seelig, J., and Schatz, G. (1981) // Biochim. Biophys. Acta, 636, 162-167.
Shapleigh, J.P., and Gennis, R.B. (1992) // Mol. Microbiol., 6, 635-642.
Shapleigh, J.P., Hosler, J.P., Tecklenburg, M.M.J., Kim, Y., Babcock, G.T., Gennis, R.B., and
Ferguson-Miller, S. (1992) // Proc. Natl. Acad. Sci. USA, 89, 4786-4790.
Shaw, R.W., Hansen, R.E., and Beinert, H. (1978) // Biochim. Biophys. Acta, 504, 187-199.
Siegbahn, P.E.M., Blomberg, M.R.A, and Blomberg, M.L.. (2003) // J. Phys. chem. B, 107,
10946-10955.
REFERENCES
77
Sigurdson, H., Brändén, M., Namslauer, A., and Brzezinski, P. (2002) // J. Inorg. Biochem., 88,
335-342.
Siletsky, S.A., Pawate, A.S., Weiss, K., Gennis, R.B., and Konstantinov, A.A. (2004) // J. Biol.
Chem., 279, 52558-52565.
Slater, E.C. (2003) // J. Biol. Chem., 278, 16455-16461.
Smirnova, I.A., Ädelroth, P., Gennis, R.B., and Brzezinski, P. (1999) // Biochemistry, 38, 6826-
6833.
Solioz, M., Carafoli, E., and Ludwig, B. (1982) // J. Biol. Chem., 257, 1579-1582.
Soulimane, T., Buse, G., Bourenkov, G. P., Bartunik, H. D., Huber, R. and Than, M. E. (2000) //
EMBO J., 19, 1766-1776.
Steinrucke, P., Steffens, G.C.M., Panskus, G., Buse, G., and Ludwig, B. (1987) // Eur. J.
Biochem., 167, 431-439.
Stevens, T.H., and Chan, S.I. (1981) // J. Biol. Chem., 256, 1069-1071.
Stock, D., Gibbons, C., Arechaga, I., Leslie A.GW., and Walker J.E. (2000) // Curr. Opin.
Struct. Biol., 10, 672-679.
Sucheta, A., Szundi, I., and Einarsdóttir, Ó. (1998) // Biochemistry, 37, 17905-17914.
Svensson-Ek, M., Thomas, J.W., Gennis, R.B., Nilsson, T., and Brzezinski, P. (1996) //
Biochemistry, 35, 13673-13680.
Svensson-Ek, M., Abramson, J., Larsson, G., Tornroth, S., Brezezinski, P. and Iwata, S. (2002) //
J. Mol. Biol., 321, 329-339.
Thomas, J.W., Puustinen, A. Alben, J.O., Gennis, R.B., and Wikström, M. (1993a) //
Biochemistry, 32, 10923-10928.
Thomas, J.W., Lemieux, L.J., Alben, J.O., and Gennis, R.B. (1993b) // Biochemistry, 32, 11173-
11180.
Thomas, J.W., Calhoun, M.W., Lemieux, L.J., Puustinen, A., Wikström, M., Alben, J.O., and
Gennis, R.B. (1994) // Biochemistry, 33, 13013-13021.
Tsukihara, T., Aoyama, H., Yamashita, E., Tomizaki, T., Yamaguchi, H., Shinzawa-Itoh, K.,
Nakashima, R., Yaono, R., and Yoshikawa, S. (1995) // Science, 269, 1069-1074.
Tsukihara, T., Aoyama, H., Yamashita, E., Tomizaki, T., Yamaguchi, H., Shinzawa-Itoh, K.,
Nakashima, R., Yaono, R. and Yoshikawa, S. (1996) // Science, 272, 1136-1144.
Tsukihara, T., Shimokata, K., Katayama, Y., Shimada, H., Muramoto, K., Aoyama, H.,
Mochizuki, M., Shinzawa-Itoh, K., Yamashita, E., Yao, M., Ishimura, Y. and Yoshikawa,
S. (2003) // Proc. Natl. Acad. Sci. USA, 100, 15304-15309.
Tweedle, M.F., Wilson, L.J., Garcia-Iñiguez, L., Babcock, G.T., and Palmer, G. (1978) // J. Biol.
Chem., 253, 8065-8071.
van der Oost, J., Lappalainen, P., Musacchio, A., Warne, A., Lemieux, L., Rumbley, J., Gennis,
R.B., Aasa, R., Pascher, T., Malmström, B.G., and Saraste, M. (1992) // EMBO J., 11,
3209-3217.
van Gelder, B.F., and Beinert, H. (1969) // Biochim. Biophys. Acta, 189, 1-24.
Vanneste, W.H. (1966) // Biochemistry, 5, 838-848.
Varotsis, C., Woodruff, W.H., and Babcock, G.T. (1989) // J. Am. Chem. Soc., 111, 6439-6440.
Varotsis, C., and Babcock, G.T. (1990) // Biochemistry, 29, 7357-7362.
Varotsis, C., Zhang, Y., Appelman, E.H., and Babcock, G.T. (1993) // Proc. Natl. Acad. Sci.
USA, 90, 237-241.
Verkhovskaya, M., Verkhovsky, M., and Wikström, M. (1992) // J. Biol. Chem., 267, 14559-
14562.
Verkhovskaya, M.L., Garcia-Horsman, A., Puustinen, A., Rigaud, J.-L., Morgan, J.E.,
Verkhovsky, M.I., and Wikström, M. (1997) // Proc. Natl. Acad. Sci. USA, 94, 10128-
10131.
Verkhovsky, M.I., Morgan, J.E., and Wikström, M. (1992) // Biochemistry, 31, 11860-11863.
Verkhovsky, M.I., Morgan, J.E., and Wikström, M. (1994) // Biochemistry, 33, 3079-3086.
REFERENCES
78
Verkhovsky, M.I., Morgan, J.E., and Wikström, M. (1995) // Biochemistry, 34, 7483-7491.
Verkhovsky, M.I., Morgan, J.E., Puustinen, A., and Wikström, M. (1996a) // Biochemistry, 35,
16241-16246.
Verkhovsky, M.I., Morgan, J.E., and Wikström, M. (1996b) // Proc. Natl. Acad. Sci. USA, 93,
12235-12239.
Verkhovsky, M.I., Morgan, J.E., Puustinen, A., and Wikström, M. (1996c) // Nature, 380, 268-
270.
Verkhovsky, M.I., Morgan, J.E., Verkhovskaya, M.L., and Wikström, M. (1997) // Biochim.
Biophys. Acta, 1318, 6-10.
Verkhovsky, M.I., Belevich, N., Morgan, J.E., and Wikström, M. (1999a) // Biochim. Biophys.
Acta, 1412, 184-189.
Verkhovsky, M.I., Jasaitis, A., Verkhovskaya, M.L., Morgan, J.E., and Wikström, M. (1999b) //
Nature, 400, 480-483.
Verkhovsky, M.I., Jasaitis, A., and Wikström, M. (2001a) // Biochim. Biophys. Acta, 1506, 143-
146.
Verkhovsky, M.I., Tuukkanen, A., Backgren, C., Puustinen, A., and Wikström, M. (2001b) //
Biochemistry, 40, 7077-7083.
Verkhovski, M.I., Belevich, I., Bloch, D.A., and Wikström, M. (2006) // Biochim. Biophys. Acta,
1757, 401-407.
Vygodina, T., and Konstantinov, A. (1988) // Ann. N Y Acad. Sci., 550, 124-138.
Vygodina, T., and Konstantinov, A. (1989) // Biochim. Biophys. Acta, 973, 390-398.
Vygodina, T.V., Pecoraro, C., Mitchell, D., Gennis, R., and Konstantinov, A.A. (1998) //
Biochemistry, 33, 3053-3061.
Wikström, M.K.F. (1977) // Nature, 266, 271-273.
Wikström, M. (1981) // Proc. Natl. Acad. Sci. USA, 78, 4051-4054.
Wikström, M. (1984) // FEBS Lett., 169, 300-304.
Wikström, M. (1989) // Nature, 338, 776-778.
Wikström, M.K.F., and Saari, H.T. (1977) // Biochim. Biophys. Acta, 462, 347-361.
Wikström, M., Saari, H., Penttilä, T., and Saraste, M. (1977) in Nicholls, P., Moller, J.V.,
Jorgensen, A.J., and Moody, A.J. (Eds.), Membrane Proteins 11th FEBS Meeting, Symp.
A4, 45, Pergamon, Oxford, 85-94.
Wikström, M., and Morgan, J.E. (1992) // J. Biol. Chem., 267, 10266-10273.
Wikström, M., Saari, H., Penttilä, T., and Saraste, M. (1977) in Membrane proteins 11th FEBS
Meeting, Symposium A4, 45, Pergamon, Oxford, 85-94.
Wikström, M., Krab, K., and Saraste, M. (1981) // Cytochrome Oxidase: A Synthesis, (Academic
Press, London).
Wikström, M., Jasaitis, A., Backgren, C., Puustinen, A., and Verkhovsky, M. (2000) // Biochim.
Biophys. Acta, 1459, 514-520.
Wikström, M., Verkhovsky, M.I., and Hummer, G. (2003) // Biochim. Biophys. Acta, 1604, 61-
65.
Wilson, D.F., Ereci?ska, M., and Owen, C.S (1976) // Arch. Biochem. Biophys., 175, 160-172.
Wilson, D.F., and Nelson, D. (1982) // Biochim. Biophys. Acta, 680, 233-241.
Winkler, J.R., Malmström, B.G., and Gray, H.B. (1995) // Biophys. Chem., 54, 199-209.
Witt, H., and Ludwig, B. (1997) // J. Biol. Chem., 272, 5514-5517.
Witt, H., Malatesta, F., Nicoletti, F., Brunori, M., and Ludwig, B. (1998) // J. Biol. Chem., 273,
5132-5136.
Woodruff, W.H., Einarsdóttir, Ó., Dyer, R.B., Bagley, K.A., Palmer, G., Atherton, S.J.,
Goldbeck, R.A., Dawes, T.D., and Kliger, D.S. (1991) // Proc. Natl. Acad. Sci. USA, 88,
2588-2592.
Wrigglesworth, J.M. (1984) // Biochem. J., 217, 715-719.
REFERENCES
79
Yang, W.-L., Iacono, L., Tang, W.-M., and Chin, K.-V. (1998) // Biochemistry, 37, 14175-
14180.
Yano, T. (2002) // Mol. Asp. Med., 23, 345-368.
Ye, X., Demidov, A., and Champion, P.M. (2002) // J. Am. Chem. Soc., 124, 5914-5924.
Yoshikawa, S., Shinzawa-Itoh, K., Nakashima, R., Yaono, R., Yamashita, E., Inoue, N., Yao,
M., Fei, M. J., Libeu, C. P., Mizushima, T., Yamaguchi, H., Tomizaki, T. and Tsukihara, T.
(1998) // Science, 280, 1723-1729.
Zaslavsky, D., Kaulen, A.D., Smirnova, I.A., Vygodina, T., and Konstantinov, A.A. (1993) //
FEBS Lett., 336, 389-393.
Zaslavsky, D., Sadoski, R.C., Wang, K., Durham, B., Gennis, R.B., and Millett, F. (1998) //
Biochemistry, 37, 14910-14916.
Zhen, Y., Hoganson, C.W., Babcock, G.T., and Ferguson-Miller, S. (1999) // J. Biol. Chem.,
274, 38032-38041.
Zheng, X., Medvedev, D.M., Swanson, J., and Stuchebrukhov,A.A. (2003) // Biochim. Biophys.
Acta, 1557, 99-107.
Zickermann, V., Verkhovsky, M., Morgan, J., Wikström, M., Anemüller, S., Bill, E., Steffens,
G.C.M., and Ludwig, B. (1995) // Eur. J. Biochem., 234, 686-693.
Ädelroth, P., Brzezinski, P., and Malmström, B.G. (1995) // Biochemistry, 34, 2844-2849.
Ädelroth, P., Svensson Ek, M., Mitchell, D.M., Gennis, R.B., and Brzezinski, P. (1997) //
Biochemistry, 36, 13824-13829.
Ädelroth, P., Gennis, R.B., and Brzezinski, P. (1998a) // Biochemistry, 37, 2470-2476.
Ädelroth, P., Ek, M., and Brzezinski, P. (1998b) // Biochim. Biophys. Acta, 1367, 107-117.
